Gene list
Applied filters:
COG category: Signal transduction mechanisms
Gene type: CDS
Genomic element: chromosome
Number of genes found: 181
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Bacteroides fragilis NCTC 9343, ATCC 25285 = NCTC 9343 >BF2344 conserved putative DNA-binding hypothetical protein MDEEVKGFNRYMSKVDFQPVTEFIFQNGQLTDYKKGEFFSRQNESCKMVG YVTEGSFRYCCTDSRGGSKIVGYTFDHSFVGNYPAFRLGDNSNVDIQAIC NCSVYVINNRQLEEFYSRNETNQKLGRQIAEILLWEVYERMISLYSMTPE ERYTEILKRCPELLNLISLKELASYLMICPETLSRLRRKLVQK >BF3661 putative response regulator MKAIIIEDEKAAVRNLTSLLGEVCPQIEIVTELDSIADTIEWFTDHSMPD LVFMDIHLADGSAFEIFEHVHITCPIIFTTAYDEYALRAFKVNSIDYLLK PIGRQDIEQALEKLTLFSSGNSKPTGPETNELVNLMRMLKKQESYKTHFL IPIKGDKLLPVSVDMILLFYIRDCQVKAVLTDGTEYSFPQTLDELTECLD PTLFFRANRQYLLSREAIKDIDLWFNSRLSINLRHSVSGEKILVSKARVA EFKEWFSVK >BF0823 putative transmembrane protein MKRLLSVFLFLFCCVIAADAQDDAAQYDSIMNLMKNKKIPLMERYYMTGD IEYLSREHQIAVLKQLIPEAKEVEDKAVITRLYSIVAMFENQLGHMTEAK NYLDSAFMNKGKFENNNISGMMHYIAGIYYSDKNLMEQAHENYYQAAEYF NRNEMKPAILTEIYYDLSIIYSMWQDDEGLHELSEAMKDLPVDFPFQQIL KWTIKAKYFYALYQNEHRVDLLDSVTKYNQEAFKVYTSTENPYDVGYVIS DNYLHQAIVYSEAGKIKEAEQCFETGKKLMNPKKIDANVSVSYVSGVIAY YQADYELAEQHLQDGLRELKRMDEEQEVDYYHALIEFYTLLAKVYEKQEL YNKALEAARNSLKYETRLFDKNSNKTIQKLRTQYNLNEKERVVEQLSAIN EKNRRINILSAILIVLALVTIFLLLKRYRSRQRIHEGMLQIAKLKQQEAE LLVKLQKTKLEEREREFQSLVHEAQQRKVQYYLEGLEVERKRLAKELHDN VSNELLAIKMKITDGTSSCEEIMDTLQTLQAEVRGISHDLMPPIFKYASL SEILQDYVYQHNQPGQTELELLLEPEDNFDNLSQKVSLEIYRIVQEAVGN SLKHAQATLVKIILVREDNKVKLTVSDNGRGFEQQTGKTGIGLTIIKERV ENLRGTLTLNSAPGKGTELIVEIDLENLEK >BF2047 putative two-component system sensor kinase/response regulator fusion protein MDRILHDVDNAHKILQLTSDTLILVDKNGTCLDIDPHSDLWFLQEDRLLG KNLFNLLPDHTFQKLLPDFRRVTQQGITVNRNYRLPLEGGETYYFKCIMQ PYDGDKVLCQYRDITARSNVKLQLERTNYELKEIQKAAQIGQWKYSSREK TFYYRGYNGIVCTEEERSINFQDYYETILSEDLPAVNTWMEANRRELLKE YIEYRILLEGQVYYMRQQCYLRNEEEDGNIVLEGYIQNITDIQRKRNDIN TLTHAINNAKESVYAARRDGTLIFANRQFRLNHRIAEQADLSLIRVFDVV GDMTCIEDWEERYRSIREGQTLNFLAYQPLKHDKNTLAFEGTMYSVTTDD GEETFWSFTHDISERIRYESQIKRFNRIMDTTMENIPAGIVVKDIENDFR YIYRNRESYNRDISSENAIGMNDFDYYPPEMAQQKRKEDMEIAATGKGMH WIMEGKDKNGNLLILDKQKIMVESEDFSPIIVSIEWDITQLELMRRELIE SKEKAETSDKLKSAFLANMSHEIRTPLNAIVGFSRIISESDNAEERREYY EIVDANNERLLQLINEILDLSKIESGIVEFTYGPVRLHPLCKEIHDAHVF RCPQGVELRFDSPDEALSIHSDKNRIFQVFSNLIGNAFKFTTEGSVSYGY KQEGERVVFYVKDTGLGIEPEKLGRVFQRFAKLNNFAQGTGLGLSICKTI IERLGGEIAVSSEVGTGTTFTFWLPLENVIQDTETGTNSHLPGEAVGTQP SEVLPAKEDTPRPKEETTEKEEDLRTTAVETEKATILIAEDTDSNFDLLN AILGRKYRLVRARDGMEAVTMYDEVNPDLILMDIKMPNLDGLEATRIIRQ LSAEVPIIAQSAYAYEHDRNAAEEAGCNDFISKPIAQEKLKEKIKKWLK >BF3208 putative two-component system, sensor kinase MTIQLLLVTGVTDCLWLYVLSLLLFLTVCFLLYQNFLLRKSASADDDYRR FLFDILDNLPFPIMVKDIQEQFKYTYWNKESELQSGISRKDAVGFSDVDI FGEERGKQYRKIDEDLVRAGIPYKAEERYVTADGKVHDTLVMKSIISSGK LGKWLLVARWEITQLKMYERELLAAKEQLEGAVCKQKLALRSIDFGLIYI DRNYLVQWEETGNIKNLVSGRHYTPGTVCYRTTGQGTQPCGKCAFREAIG TGKIVRHITHVDHVDFEITATPVYDDTGNEIIGGLLRFEDITEKLKVERM LQEAKEKAEESNRLKSAFLANMSHEIRTPLNAIIGFSDLICQTDDVEEKE EYIRIVTSNNELLLQLIDDILDLSKIEAGTMDFSYAPTDINELMEDICLQ MQQKNQRPEVQIMFTEKEPGCVINTDRLRLSQVIMNLMNNAMKFTSEGSI TLGYRLTRQKDELYFFVKDTGIGIPADQAGKVFERFVKLNTFIKGTGLGL AICRVIIERLGGTIGVETREGKGSCFWFRLPVREDMLLESPVR >BF2959 conserved hypothetical protein MITVDTCGMTNYSPLIPAIKAMCNANPGDKMEIVTDQVAAFQDLKEYLSE QGIGFREIYDGERMTLQFTIL >BF1513 putative anti-sigma factor MDDELLIAYFKGEVSDEETQRITEWIEAEIEHQRYYQQLCRLFEMSYWIE DMSEQTEVALPKKAKILPWKHYAISFMKVAAIFVLGFALHFFLNRQTTTT HHELQHQIHVPTGQHVEIMLADGSKVWLNSGSTLTFPSKFNGKKRLVELD GEGFFEVKSDKEHPFIVSTSKYQVKAVGTSFNVYDYQDSPQFEAALLNGK VEVTTNAKKSSAVILTPNQRAALCQGVLKVKPIENTNNYLWRKGILYFNE PLLEVFDKLQEYYDVEFQIRNTSLTRKSPYCTGKFRAKDGLEHIIRVLKE TNHFDYQIDYENKKIIIL >BF0242 putative two-component system sensor kinase MKQLILSGMFVVCGLSVSLASEKWAVDSINWHRAEQKMQEKDFQDAALTY KELITKGDSLFVDYAGRHVEDMREQYSIDELDLQNGMQQKKIWKLVFITI LCLVVLLFVGLLYLRRAERKLLFSREELQKAKRLAEESVRNKSVFLSNMS HEIKTPLNALAGFSEILITPGIDDEVRAQCNDVIRLNSDLLLHLVNDVVD VSCLDVANMRFSVVPHEVVALCRNVVEMLRNIKQTSAEMIFETELSALEM ETDPCRLQQVLINLLVNATKFTKEGYITLTLRINEAGVPEFMVTDTGCGI PLENQEAVFSRFEKLNEGIQGTGLGLPICKLIINRMGGDIRVDSTYSKGA RFIFTHPLKQEENR >BF1606 putative two-component response regulator transcriptional regulatory protein MNTGTILIVDDNKGVLASLELLLENYFSKILTASNPNQITALLTTHRIDV VILDMNFSAGINNGNEGLYWLGHIRQMAPTLPVVMLTAYGDVELAVKALK NGAADFLLKPWDNQTLIDKVTEAYRSRKAPEHTAKVDRAEGFEMLVGRSP AMLQLMKVVSKVARTDANILITGENGTGKEILAREIHRLSPRGARPMLNV DMGAISESLFESELFGHERGAFTDAHESRPGKFEAANGSSLFMDELGNLP LPLQTKLLTVLQSRNVTRLGSNKVIPVDIRLISATNKDIPEMVKQGMFRE DLFYRINTIHLELPPLRERGDDILLFIDCFLRKFTSKYQRQEIRIHEQTV EKLRSYHWPGNIRELQHTIEKAVILCEGSVIRPKDILVKQTWQPQATATV PNLEEVERRAIETAILQNNGNLTAAAEQLGVSRQTLYNKLKRFKL >BF1651 putative solute-binding protein precursor MNLLRPKYLKYVVLGLISALVVTCWPRKEKPKGHPRDYAEIKESGILHAA TEYNSISFYVDGDTVSGFHYELIEAFARDKGLQVQVSPVMSFNQRLEGLA NGTYDVVAYGIPATSELKDSLLLTSPIILSKQVLVQRKVGENDSLAIRSQ LDLAGKTLNVVKGSPSILRIRNLSNEIGDTIYVNEIEKYGSEQLIAMVAH GDIDYAVCDEGIARMAVDSLPQLDINTAISFTQFYSWGVSKQSPALLDSL NTWLSDFRKKGEYQSVYRKYYGKQ >BF1139 putative two-component system sensor histidine kinase/response regulator fusion protein MAMAHTLDSFPDTGDLENLKDNYQKITSVLAGHQIAFWEYDIPTGECNFT DEYFHILGLKEAGIIFRDINDFYRFAHPEDVISYQTTFARMLESETKISQ IVVRCVGRRGETIWLEDNFIAYKKNKENGSDKIIAYTANITSRCEKEVQI RQLEERNRKIIEALPEFIFIFDDNFFITDVLMAPDTELLHPVEVLTGADG RSIYSSEVSDLFISSIHECLKSGKLKEIEYPVDVEAGRHFFQARIAPFEG NKVLALIHDIGDRMRRSQELLEAKQRAEEADRMKSVFLANMSHEIRTPLN AIVGFSEIIALTEDEKEKEEYLGIIQQNSNLLLQLINDILDLSRIESGKS EMHCQLTEMSGLVDEVDKVHRLKMKKGVKLNVIRPSEEIWISTDRNRVTQ VLFNFLSNAIKNTIEGSITFGLVKEEEWVKLYVTDTGCGISKEKLPLIFT RFEKLNDFVQGTGLGLPICKSIVERLGGRIEVESELGQGSTFILYLPNRQ VQEVVVGERENAAGNMGVENRQKKILIAEDVESSYLQINAFLKKEYTILW VPNGEEAVKSFIREKPDLILMDIRMPVMNGIQATAKIRAISQEIPIIAIT AYAFCPEGERALEAGCNEVIAKPYPLEKLKETIETYL >BF3164 putative two-component regulator sensor kinase MKSMRSIHSLIRCCMILLLLTSCYSKEERRVLVIHSYEKDYQGYAEFNKL IKKEFAKAHIPVELTFFYLNCEINNEQQEIDKINNFLDSISKWKPEVLLV NDDQATYSLLETHHPLLKGIPIVFSGVNYPNWELIGQYNNVTGFHDKIDF RKNLEMVHKLTGKNHIYTILDFTFLDRKVRNDIDNQLKSTDIISNLDWHL DKNDTRKEAEKGHIIINALSARNLSKNQNKDQTKGGDFIWSISKYSTLPY LQTKFDYTTVTMASLSTRQRFTTINELFDCGHDFLGGYITPMHIQVEESV HAAARILNGENVADIPIQESAKGYFIDWNAMQKEHLAIADIPHEYTIINI PFKTRHPIVWWFALLGSITAIVSLLSGITYLYWRETKRKRSILYELEDEK ESLALAVEGSDTYAWRLKDDTMVFEYAFWKNLGMAPHPLTIDGFLSFVDA DYLDTTQALLTKNATNGKHFIKLKCDFNGTGYQWWELRCSTMKSALGGQK TTGLLLNIEDYKKREQELIEARKMAEKAELKESFLANISHEIRTPLNAIV GFSTLLASPDDTDITPEEKEQYIDTINRNSELLLKLINDILELSRIESGY MSFDCDDYPLDALIRDTYQTHKILIPGQLHFLLEEGEKGLIVHVDKNRLV QVITNFLNNASKFTREGSIKLGWSYMPQTEEVEIYVEDTGIGIPQSEQKM IFGRFYKQNEFAQGTGLGLSICKLIIEKLQGRLSLRSEAGTGSRFSIFFS CKKQPI >BF4179 putative two-component system sensor kinase/response regulator fusion protein MKKSTFTLILFFSSVILYAQQNELMFHSLGSQHGLTYSAVRDILQDSKGY IWIATLKGLNRYDGYNIKQYYKSDDGLSSNCIEKLLLLGQDTLLMGTNEG LCLYDMMREKFTTIVPQTKAPLYVLDMAYDGRSVFIASDSGLYAYSKTEQ SMPLLHKGLIVKVTLDMNGNVWAVSPNTIYCFRPNGQMTRKITATEVSPD YPVEFTSIYKDSQGTLWLGTTENGLYRYNKNYNQFVSVEFASQDRKDMRY IRCIQEDMRGNLWIGTENGLFIYDYTDNSYIQYRQHAKDVQSGLTDNAIY TIYKSRGDIMWIGTFFGGVSYTSLTENNFHYLIADNGKQYLKGKAISNII KDKNGALWFASEDHGISILYPDGHIRYLNKSTHPSLNGDNVHALAEDHSG NIWIGNFIDGLQKVDLAKGYIRSYKNIAGGHAGLSNNSIYKLYVHNPDTM FIGTSQGVNIYHFRTDSFTPFLPDVFRLIRIDDITRDLKGNIWFSTHFNG IFRYHIPTHSIHRYQKGVTGCKTMTSDNIYCSFVDSKGEVWFGTSNGGLM KYNARADSIQAFGKENELRQRDIYSIQEDSFGYLWMSTDNGIFSFNPESR SFAHYKVSDNLVSNQFNACPGYKDPDGTLFFGSINGVCFFRPEGLNHNSP TNDIHLTFSDFRIFNKHVQPSPDGILQNNIDSTSVIRLPHGMNTLTFDFL VINYNENCQSQLSCEYYLEGMETEWNATQQIPQSVTYTNLDPGTYQFHVR VIGKNGVVFDRRKITINIRPHFLLSGFMITIYSLIGLLISFIIVRFYQVR MRDKMDIRIERMEKNNLRELNKHKLNFFTYITHEFKTPLSILMAVFEDIS IGRNNTITGEEMKIINRNIQRLQFLINQLLEFRSVETDHARIEYVKGDIM TYGRSIFELFIPVFRQKQIVFQYATSADSYYTVFDRDKIEKIISNLLSNA FKHSDPQSEINFRIDVDKASGQLILSCHNSSSYIHPEQREAVMQPFHKTD SSDQKYSNTGIGLALVNGLVQLLSGTVEIESHQNSGTTFKVKLPLVEDSK DMIAPDETLDIVNSPDVVADTVYLLNNSGLKEDMNAANAEKKMTVLLVED NPDINNILKSKLLRLYKVKTAYNGQEAVELLKTHIIDIIISDIMMPYMDG YELSKYIKTSREYSHIPVILITSQPSKENELQGLSAGADAYIEKPFTFDE LNLRITNLLKAKNNIREHYHDMKIFQLNEELNNKDEEFIKSLTQFVIEHI ENPELSVDQPTTHMNISRTQLYNKLKKLLNLSATEFINKIKIDVAKVKII KTNLTIAEISWQLGFNNPSYFSKTFKRFCGVTPNEFKNGKSQ >BF0552 putative LuxR family transcriptional regulator MMNHQPEIAIVEANTLTSLGLKTILERMIPMAVIRTFHSFGELTDDTPDM YAHYFISAQIYVEHNAFFLPRKRKTIVLAGDSHQFQLSGVPILNIYQAEE QLVKDILKLHQHAHHDGYPVKDMPPTPPTTGHELSAREIEVLVLITKGLI NKEIADKLNIGLTTVITHRKNITEKLGIKSVSGLTIYAVMNGYVEADRI >BF3573 putative anti sigma factor MKNEIKDINEVIIRFLDGTATGEEKVFLFNWLKQSEKNRNEFSEVRDLWL LGNTIATDDLETEIALERFKNRIQSTESGLRKNRFVFRKHFVPFLRVAAV FLMLFTVGSVFYYWGSSSVPKQPDVMNRLLTANGSKGRFVLPDSTVVWLN SNSLLEYPETFSSSAREVSLSGEAYFEVRRNEKLPFRVQAGEMKVEVLGT RFIVDNYRRKSGVEAVLVEGSVKIAGCKMNHSVVLTPGQLINYDKKSERT KVQMVNTDDYISWIQNELTFDNDKLADIIINLNKWYGVDIECPSEFAEKV FMSFSVRNGENLDEILKAMTLVAPIRYYWENGILHILPRKR >BF0169 putative two-component regulator sensor kinase MKIRSILTIKYAGITATIFLVFMATIYCVNEHLRSDSFYRSLRSEAITKA HLFLNNQVDVETMQSIYLNNRQFIDEVEVAVYTPDFRILYHDALHNDIIK ETPGMIDEIVRKKEIDFRTGDYQGIGILYEFGGKNYVVTAAAYDRYGHIN QVIMTRLLLLLSIGGLSVLVIVGYMLAKSSLAPIRSIVRKAEGITVTQID ERLPVKNEHDELGELALAFNALLDRVEKTFNDQRMFVSNVSHELRTPMAA LSAELDLALQKERTVTQYQNSIHNALQDSQRVIELIDGLLNLAKADYYPE QIKKEEIRLDELLLDANELVLKAHPDYHIELIFEQEADDDRVLTVIGNPY LLTTAFVNLIENNCKYSDNRTSFIQISFCDQWTIVSLSDNGAGMSETDKE NLFKLFYRGENKNQAQGHGIGMTLTKKILTLHKSEISVYSHQGEGTTFVI RFHHL >BF2173 putative two-component regulatory system histidine kinase MSNSSIKSKTALLRNGETQKGNGYPEANDYSARILETMQTGVVFFNTEQI ISGINNLACEDLQIPRDPSGHKITDIISIIHQEKDIFPELIARLKSSETD MEKLPIDTLIRSLETKVQFFASGCIMQLETGRYLLAFRNTMDEVTHEHLL SMILARTKIFPWFFDLKRNKMLIDAHWFSYLGIPAGDCEITIEKFFSRVH PNERDMLADALQKQLSEKEIPDSFSYRLQRGDGSWEWFSEQSMYLSKTND GSPYRIVGVCHSIQEHKNTEDKLRAARNKAQESDRLKSAFLANMSHEIRT PLNAIVGFSNLIAGGIVDLDTEEARDYSALISKNCNYLLTLVSDVLDLSC IESDTMTFKFTVYPLTRLLTEIYQKYENRIPQEVQFNLLLPTDNVEIETD AVRLRQVIEHLLDNAAKFTVKGHIDIGYALSDHGEKIYVFVADTGCGIPS DQYKKVFERFYKINSFVQGAGLGLSVCKTIVEGLGGTINVYSQLKEGSRF SVILPLNRLHK >BF2647 putative two-component system sensor kinase/response regulator fusion protein MNKQTSTPSQIHRLQQTIYENLPVGMELYDGDGYLIEINSVGLKMMGVKD KQDMLGINIFENPNIPVEMKRRLRAGENIRFTVKYDFDLAKAHYPTVLSG ISYFEITVSVVLDENKEIDKFLFIAQDVTEAVHTQEILRQSKQKTALAMQ AAEVMLWEFDVRTRLFYAENEPLNGYDPTQALTIEDYKKQIHPEDWKKAE IILLDMLSGCDCLYEIDFRIRLSDTSEWQYCKLNCTPYERGTDGKVIKYV GFRKNNTELQRRKLLQENILNSIPLPIHIKDVEDDFRYVFCNEESMRMFG THEGETVCSVLDSEQAERMQKTDLEVFTTGKPYFGVERIILKDGRSYDTI VRKNIIYDGTKRLLLNIRWDQKLQNDFKRRAKVLSMSMEVMNAYTWFYEP SKQRVSFGEGFDKIGRNALDINSFEKFAECVHPDDRQRFVDTMDAVLKQD SGEWDIEYRADLRRNGNYEWWKTRGVLETSILNDHPYQYVSGMSISIESY KQTELTLLKNKEKLNKLIRQNELVLNNTNSGLAYITTDYVVQWENVSVCS SSLSFEAYKRGECCYKSAHNRTSPCDNCVLSKVLVSRQMEKIKFHLENNR IVEVLATPVFNESEEIDGIVIRVDDITDRERMIEELRQAKLLAEQSDKLK SAFLANMSHEIRTPLNAIVGFSDLLMNSEEQGDKEEYMQIINTNNELLLK LINDILDLSKLESGSVELKYEEFDLAEYFDSMASSMKQRVTNPKVQLVAV NPYSVCRVRLDKNRVAQVVTNYVTNAIKYTPQGTIEMGYEVVDAGIRLYV RDTGIGIPEEKKRKVFHRFEKLDEFAQGTGLGLSICKAITESMGGSVGFE SEYSRGSLFWAVLPCDPEVQMRRESNIAIGQNAGKDDLIRSGNQHSALDR KTVLVVEDISSNYLLISAMLSKHYNLLHAVNGEQAVAMVKEYKIDLLLMD MKMPVMDGLTATAEIRKFDTNIPIVALTAHAFESDKVAALKSGCNDYLVK PVDKARLMSVLRKYCHPSTLVL >BF0231 putative regulatory protein MRKNKFKSFASRLNKDGDHPEKISFESPEEQAEYDKLDFLWNRCLPEETG EPDIWAKVQAKINADNTPVRLALKSNKTARLFSILKYSAVAASVALLIGA GCFLLLNDEERHDLNKIAQSLQTEIPQDIKEVTLVVSDQKKIELDNNAQI VYSATGQVQVNSNKLVEDDIKEEYNQIIVPKGKRSQIVLADNSKIWINSG SKVIYPRAFEGKYREIYVEGEVYLNVTHDTSKPFIVNTSGFEVRVLGTSF NISAYKNQEKAAVVLVEGSVNVKDQQNHHIKMVPNEKVELNQEGISGKEK VNARDYISWIDGIWTLQGESLKQVLLRLQDYYGQNIRCDAEIENEQMFGK LFLNDDLNQVMKSILSILPAEYTMKNNVIYIE >BF2450 putative two component system response regulator MEQLGKILIVDDNEDVLFALNLLLEPYTEKIKVATTPDRIEHFMTTFGPD IILLDMNFSRDAISGQEGFESLEQILKIDPQAIVIFMTAYADTDKAVRAI KAGATDFIPKPWEKEKLLATLSSGMKLRQSRHEVNMLKEQVEVLSGQGGP ENEIIGESEAMQEVFSTINKLSETDANILILGENGTGKDVIARLLYRCSP RYGKPFVTIDLGSIPEQLFESELFGYEKGAFTDARKAKAGRMEVATGGTL FLDEIGNLSLPMQSKLLTAIEKRQISRLGSTQSVPIDVRLICATNADIRA MVDEGNFRQDLLYRINTIEIHIPPLRERGNDVILLAEFFLERYARKYKKE MHGLTREAKNKLLKYNWPGNVRELQHTIERAVILGDGSLLKPENFLFHSS VRQKKEEEVLNLELLERQAVEKAMRLSEGNITRAAEYLGITRFALYRKLE KLGL >BF2205 putative regulatory protein MTYLATNPLFHGISPETLSRDFDGIISHLRMFRKGDILARQGDVCNRLMI LLKGSVRGEMIDYSGRLIKVEDIIAPRAIAPLFLFGADNRYPVEVTANEA TEVFEIPKESVLKLFRRNEKFLENYMNLSANYARTLADKLFFMSFKTIRQ KLASYLLRMLKQQGDSPIQLDRSQQELADYFGVSRPSLARELAHMQDDGL IKTDRKLVHILRKEDMMQLIQ >BF2252 putative two component system response regulator MKEKIKVLLAEDELTLAMIIKDTLEEDDFILTIAANGEEGLRMFFDIRPD VLVADVMMPRMDGFEMVRRIRQTDKQTPVLFLTARSAINDVVEGFELGAN DYLKKPFGMQELIIRIKALVGKAFSFNEEKKTTTRFEIGNYLFDSLAQTL THAGLKQELSHRESEILKRLCENQNQVVNTQNVLLDLWGDDNFFNSRSLH VFITKLRHKLSADERIRIVNVRGIGYKLILN >BF0164 putative two-component system, response regulator protein MGKKLKIFFIDDDIALGHICTRIMQEEGYEVLYQTSLNGAKACIVETHPD MIVLDVEIGNKNGIEAVPELKAIAPNTPILFISSHTNSQLVVQALSAGAV AYLKKPLEIDELIAYIKRYAISHPYQIKIGSLILDTDTQLLCTKELRVIK QLSEAEYKLLKLLVAYKEQLVERRQIEEELWGKVNGNEQGINNLISKLRK YLSIDPTIELVTIPRNGYKLSVNLS >BF1176 hypothetical protein MKTMKFILACVLLLSPLLCQAQKNLFNKYNDMKGVSSVYISKAMMELNPN LFMKDLYIGKVAEHLNSVQVLSTHDNKVREEMAKDIRSLVQSSKYELLMK QKSTVSGSEVYVNRKGSKVKELIMVMNGASSLKFVYMEGDMTTDDIKKLM LYQSTSQNFIISGDLFYANNKPVTYFKKGNSDNQKDMAELSGTYNLNSID TNYKEELSTLNDKLKRIDQGLKNMNIK >BF2282 putative two component system response regulator MEDKKFKVIIVEDVKLELKGTEEIFRHEIPNAEVIGTAMTENEFWPLMET QLPDMVLLDLGLGGSTTIGVDICRNIFKRYPGVRVLIFTGEILNEKLWVD VLNAGADGIILKTGELLTKTDVQAVMDGKKLVFNYPILEKIVERFKKSVA NDAKRQEAVISYDIDEYDERFLRHLALGYTKEMIANLKGMPFGVKSLEKR QNDLIGRLFPQGERVGVNATRLVVRALELRIIDLDNLEADEE >BF0365 putative FNR-family transcriptional regulatory protein MVKVEFTDEYQKILWQISLFKDMDNSLQRRLPQELELSVYEVARKEIVLK QDTYCNHLYVLLKGELEVNIVDVAGNLVKVEDIRAPRAFATPHLFGDKNL LPATFTASEDSVLLMATRSSVFKLISSVPDLLHRFLCVTGNCNKCTVTRL RILSYKMLRSRLVYYFMEHKISPDTALLEHNQVQLAEYLGVTRPALSKEI NKMMKEGLISINKKVVTLEDMAALKEYI >BF0841 putative phosphate starvation-inducible PhoH-like protein MIEKLIVLEDIDPVIFYGVNNANIQLIKALYPKLRIVARGNVIKVLGDEE EMCAFEENITKLEKYCAEYNSLKEEVIIDIIKGNAPQAEKAGNVIVFSVT GKPIIPRSENQLKLVEGFAKNDMVFAIGPAGSGKTYTAIALAVRALKNKE IKKIILSRPAVEAGEKLGFLPGDMKDKIDPYLQPLYDALQDMIPAAKLKE YMELNIIQIAPLAFMRGRTLNDAVVILDEAQNTTTQQIKMFLTRMGMNTK MIITGDMTQIDLPASQTSGLVQALRILKGVKGISFVELNKKDIVRHKLVE RIVDAYEKFDKEKKAEREKLNGERLTISKERQNVGNL >BF4286 putative two-component system sensor kinase/response regulator fusion protein MKNTFCVLACFFITIFCQAQSVEEHYYFKNLSIRNGLSQNTVNAILQDRK RFMWLGTKDGLNRYDGLSFRKFKHDAANPRSIGNSFITSLYEDFNGNIWV GTDAGVYIYYPEKEAFEEFDCQSLEKTRIERSVSMIAGDKQGRVWIAVEA QGMFCYDTRQKLLRNYPLSEISSNIKCFTFDSGGTLWLGFYGDGLYYSKD NLATVHPYGSPEDGKREFEGGVITKIVQGNYNCLYIGSVKEGVSELNLTS GQVRNLLAIDESGESIFCRDLLPYSDNELWIGTESGIYIYNLRTAQFIHL RASLYDSYSLSDNAIYALYKDREEGLWIGSYFGGVDYYPRQYTYFAKYYP KNIANSLHGKRVREFCRADDGTLWIGTEDGGLNHFNPKTKEFHFFEPSAG FTNIHGLCMDGSHLWVGTFSKGLRVIDTRTGVVLRTYTEGHTPHSLNDNS IFSICRTSAGEIYLGTLFGLLRYNRTQDSFDCIPELNGKFVYDIKEDSYG NLWLATYANGAYCYDVSARRWKNYVFDAEDERSLPYDKVLSVFEDSYRQI WLTTQGGGFCLFHPDTETFTRYGLKDGLPNDVVYQIVEDDDRFLWLTTNN GLVRFDPKTMEMKVFSTANGLPTNQFNYRSGFKDEAGNIYLGSINGFVAF DPRTFAENRQVPAVAITDFLLFNKEVPVGETDSPLKSSITFSDKVVLTAD QNSFSFRIAALSYQAPRMNKLMYKLEGFDEGWLTIGESPLVTYSNLGYGD YVFKVKASNSDGVWNEQETSLHLSILPPFYLSGWAYCFYVLFFMGCLVCV IFYFKRRNYRKQHRQMEMLEQEKEREVYHAKIDFFTNVAHEIRTPLTLIK GPLENIILKKEVDSETKEDLYIMKQNTERLLNLTNQLLDFRKTETRGFRL NFTECDVVAVLRETYLRFTSLAKQKGLDFILELPQECFMADVNQEALTKI ISNLLNNGVKYASTYLRISLETDEKVFHIRTFNDGEMIPDTMKEEIFKPF VRLDKEDEVTTGTGIGLALSRSLAELHQGSLMMEKGEEVNCFCLTLPVNQ DSTITLSAENVSQVEENSCGWEQEETDTKEKKPMILVVEDNPDMLAFIRK QLTTEYSVLTAMNGIEALAVLDNHYVNLVVSDVMMPQMDGFELCKTIKSD LSYSHIPVVLLTAKTNIQSKIEGLELGADAYIEKPFSVEYLLANISSLIH NREKLRQTFAKSPFVAANTMALTKADEEFIWKLNDIIQANLHNPEFSMED MADALKMSRSSFYRKIKGVLDLSPNEYLRLERLKQAAQLLKEGKSRVNEI CYTVGFNSPSYFSKCFLKQFGVLPKDFIG >BF3750 putative membrane protein MIDFDYSEWAILRFIGASFVLWLCYYLLFDRKAPFNQCRNYLLFSVLLAG AVSVLRIPVYPVEVVKPVKMEQIVVAQEAQTDKVSLMQIDNNGIQPDTLA TAMLTDVNEAVTHQTEEEIVEEPFYVSWNYWQIAWIVYGSGVFILLVHLL VEMVRIWRLKRWGTCTTDADGICIVRNNEVVSPFSFYRMIFINRKLEGEV LRVVLLHEKAHIRNHHYRDTLFIEGLSILCWFNPFVWLVKRELRALHEFQ VDRCLLSGEIELFEYQSILFEELMGYSPKVANGFHNSLIKKRFIMMKHQY KERLAGVRKIALLPLCIGVLALFSFTENPVLVEPVLPMVSVTIKAETPKV VLPEVTVDSAGNEKNFLLLDTPKIVHYVQSRDAHIVQSGAGQPLAQVSIF VPKVLDTLSAESSDGTFSQEQNINHTVDIDLRADQVVLSRAPRKNNAYVR FIERSKEDTRVTLAIPIHFDRHWLQFEKGLSIVDEDSKDVYRIRSVTRGI ELNRVYWVVGQEGQMLEFTLVFPPLDRKVKTVSIRDCFPEEKGLTPPNGG AWTLDNLKVDNFQPTAVRQAEYDREGRPLRSDKLEEVTLNANQLSVSSRH NGGRTQIQKIETLPDKTLVVLSVPIHYDRNWLVINKGLCIVDCKTGDEYP VLEEAHGIEMNKLLWVEGCQGSSVLLTLVFPKLPKRVKTIDFYNKYPDAG IISPTNGSSWNWWKIKIKDYQKEPYKRVIL >BF2729 putative membrane protein MLSFIYCTSYMRYCILIFGFILLFFLPVGCKQSSTVTPLSFKEWMTHHPG ECIEHYMGLHDSLFEAGRYDMLTDIYSGMFLYMPSDPDGNPDTLRRQLLR IMPLYNQVLSKTGAYEAAVQLLDSIRLSGHPFLTGYCAYPLWAFEAQNSL MTDDNRRTEALADSFAVLLPPDDQSVVMLCCHMVSWAYHFSSARPNVACR MQERAVEAYRRGGETQDVGAILARLGYYYRREGRYVKAVDLSLAAVEWYD KHPGIATDGMIRAYADLAALYSTLALTEKALEINARVIRMAAREDSMALC GAYRVRSSFFMDLEQVDSAAFYLGKEREVAQRMGERSLKTWRRDRAKYWL QMCPDSNAAALRDMEAIFADSAGVRPATHSGTRYWLGLALVRDGQEERGL AMMEQAHCEFAYMDWDEMEAFAAKGLLGIYASRHLGSRMLEFYPRYAALQ DSLNEKDKLRYTAAANVRYDTGRKEQEYRALMAEVELKERTLTYIGIVVV LLFMLLGLVVVYMLQRRRHYRREAHLHRERLSRLISIHQELNGRYESLNN ELEKVAHADVIDNVRQKLNPMLLSGDDEIRFRQSFAALYPHYLPVLRCQC PELTRNDELLCMLIRLNQSTDEIALALGISRASVNSGRSRIRKKLGLGKD ESLEAYLQNIKK >BF0395 putative two-component system sensor histidine kinase MSSKPYRHFIALLLVLFCSRFEAQAEDLFAKTDSTLQQYLIRCKAQIKDP DFLQTNDTLTRMAQEKNDKRMQVIAVALKLDYYYYQNNPDSILVMVDRVK KISRRNNELKYFYFAWGSRLIIYYIKQHQTNTAIYEARKMLQSAEADNFI PGIVQCYRTLGTVYMTQSNPKLAYENFRKQIALIEENEIEDINLPTQYAS LAQCALEMHRPDEALKALEKGSKCTRSSYQIFTVQKAYILYYLETKEYEK ARKTLVELEQLFEKDKSLTLYKSGLFYIQIEYYRNTGQYRKALDVIEEIK NDSSSINKYLDYTLTQKQGDIYWEMNQKARAAQYYRDYILATDSIRSQEI QNSTNEFYTIMEVEQLHKEKNELLLHMQEEKLQKINIALVSLVIILVAGT MLLFHISKLNKKLKRSEAKVIQQNKELVENGEELRKAKEQAENASRMKTT FIQSMSHEIRTPLNSIVGFSQVLSNYFKEEDNDEIREFASIIEISSSNLL RLINDVLDISYLDQSEILPYDKPEDINNCCLLSIERTRNSIKKEVSLRFE PSCGPLMILTNPERVAQILTHLLHNAIKFTDKGNITLAYTISPTEKQIVY TVTDTGKGIPVEQQEYVFERFAKLNDFSQGTGLGLPICRIIAEKLGGSLI IDKTYTKGCRFILTLPLIKAD >BF0569 putative anti-sigma factor MKIDDAIIDKVLNNEASVEEAGLVAEWFATEEGSEYLSGRLESESARLTE ERAREWLDHPVPEERMRERFIGQIKPEKKIVSYRRGLIAAAVLIPFLFLS IFLWFLADRTGVFSATEYAELKVPCGEQMQVVLQDGTVIQLNSDTRLRYP KKFGLFSRSVELWGEGFFVVAKDKKRPFIIDLKGVEVKVTGTKFNVKAYP SEPNVWVTLEEGGVLLKDTKNKEYPLVPGESAEYNRTSGICQITKPDDMS QISSWRSNSLNFYLTPLRDIIKVMERQYDVHFVVRDSTLLNNRFTLSTSK VNVDDVLRDLEAVSWIRFLQTEDGGFEIQKEK >BF3597 conserved hypothetical protein METFIEKFRNSYHLSENDTQTLLSYMEEIRFKKKEVIVHEGSKNGNLYLI KQGIWRAHYLKDGVDTTIWFAGAGEAAFSVWGYVENTASHITIEVMCDSI AYCIPGSTLNNLYASSLGLANLGRQLMERQLLSLENWLISAGSPKAKERY LTLIKEHPELLQNVPLKHIASYLWITPQSLSRIRREMKM >BF0502 putative anti-sigma factor MNQEILNRYLTGDASAEEKQMVVRWLDADPQHMREYLALRKLHDITLWQE KPAATVDKKKWLTLPYIREFIKIAAIFLIAVTSVYFLAPERGRDTPDLKA IHVPSGQRAELTLGDGTRVCLNSNTTLTFPDHFDRKERRVTLDGEGYFQV AKNEKKPFIVQAKEYEVRVLGTEFNVMMYKDQDFFETVLLKGSVEVNETT TGRKVKLQPNERLFGKAGQLRKESINEWNRALWMQGILYFDNTRMDEIIR QLGLYYDVKFILEKESLANVRFTGKFRIRDGVEHVLKVLQLKCKFTYQRD EDSNTITIN >BF4262 putative two-component sensor histidine kinase with PAS domain MGHYEHKTKEELLEIVCKLEKKVEGLSSELDSLKKGRFRERYSTRILDAL PDMLTVFDHNANIVELASSPTTNHVEGTTSDSIINSNVKDIVPEEAYESV RHNMDKVIHTGKSSTAEHSLMLDGVLHHYENRIFPLDDQYLLCMCRDVSQ ETEMAKINETQRSEIVRLNSLMNDILNNIPVYLFVKDTGNDFRYLYWNKA FAEHSGISVQRAVGSTDADIFPDKKDAEHFREDDLKVMKLGRIEYLENYT TMSGEVRTVTTMKTVVPSGGQHPYIIGVSWDVTEIKKTEKELIAARIKAE EADRMKSSFLANMSHEIRTPLNAIVGFSKLIIEADNECEKRQYADIVEHN STVLLNLFNDILDLSALEAGSLELSYHPVRLKDICLQLYELHVKSVKPEV RLVLDEVDSQLCIQGDWERISQVLVNLITNAIKFTSVGEIHFGFQKKADM VQFYMSDTGKGIPAERVATIFQRFGKIDDFVQGTGLGLTICRMLVEKMGG RIWVRSKQGEGTVFYFTLPMAK >BF4153 putative two-component regulator sensor histidine kinase transcriptional regulator MKISTLILTILVCFSTIVDAQGTQNRANELMKQAQSSLEQKEYTKARYLF IQAYGAFATQENYPKAVECGIQGAALYHRENYYKEAFDLCRGMDQLVWAG EQKQQKQFYPLRFQITKERLQMYIGLKNAAQAKIQLDKLAETAGLAKNDS LSENLLYTQASYYYTFGQNTQGDACFQKLINQYKAQKNYDKVNECYKKLI AIGRKSNNASLVARTYENFIVWTDSVKAMTAQDELNVLKRKYDESQQIIQ EKEDTLSGKQYMIVGLCTLVVILIAGLIFVAIVLLRFIAGNRKLKKSVQI ANEHNELKTQFIQNISAQMEPTLDTLASSAAELSDKAPQQAQQMQGQVAA LKKFSNDIQELSTLENSLTEPYEMKEINVNTFCEATMDKVKEFVQPEVST VVNAAKLQIKTNPEQLERILIHLLKNAAEYTESGKIFLDFKKRGAHTHQF IISDTGTGIPVEKQENLFKPFTEIKDLTEGDGLGLPICALIATKMNGSLT LDTSYTKGSRFVLELHT >BF2551 putative lipoprotein MKKTYLWTAMLCTAIAFSACKSNKAGQDTASEAKTEEAVIPGSDKDEHGC VGSAGYVWSEVKKDCIRPFEAGLKISETQKDNATYATYIVFAADSVQAEL YTPESEGSILLERADNQWKNDTISVSCKNGQWSISKQK >BF0527 putative two-component response regulator-like protein MSKILIIDDEVQIRGLLARMMELEGYEVCQAGDCKTALRQLELQMPDVAL CDVFLPDGNGVDLVTEMKKKSPGVEIILLTAHGNIPDGVQAIKNGAFDYI TKGDDNNKIIPLISRAVEKARMNIRLDKLEKKMGLMYSFDSILGESKALK EAVSLARKVSVTDVPVLLTGETGTGKEVFAQSIHYSSKRARQNFVAVNCS SFSKELLESEMFGHKAGSFTGALKDKKGLFEEANNGTIFLDEIGEMAFEL QAKLLRILETGEYIKIGDTKPTHIDVRIIAATNRNLPAEIAAGRFREDLF YRLSVFQVHLPPLRERTGDIKILAESFVRSFSEKLSHPVNRIAPAYLEAL CQQPWKGNIRELRNVIERSLIVCEGDRLDVDDLPLEIQNSHYEKSDEGMP GSFELSAMERRHIARVLEYTKGNKTEAARLLKIGLTTLYRKIEEYKL >BF3660 putative membrane protein MYCLIFVPMKRIRAIYNDKYLLSTLIISLAVAVLIHFPESVSLFDGFESH TLFPGMKFADVANEILFTFLSLLILFAVNTRLFHFNQTSMKITWQKIILS FVLTWILSNFLGQCFVYLHKTFDIPAIDAMVHHYLHPLRDFIMSSLVTSS CYIIYLIRRQQQVIVENEQLKAENIRNQFEVLKNQLNPHMLFNSLNTLRS LVRENQDRAQDYIQELSHVLRYTLQGNESQCVTLREEMDFVSAYIFLLKM RFEDNLRFEINITHNSEEYLLPPMSIQMLIENAVKHNEISNRRPLTITIA TDSEEGLLVSNPLQSKLTATTGTGIGLVNLDKRYRLLFRQEIQITEDRNF TVRIPLIRKDL >BF2532 putative two-component system sensor histidine kinase MMISKNPLGDIAKLNRICASAQIGWWEVNFTTGKCFISETLLKSLEVSSE WLDIDELMSTVRQDYRKRITDEFTSIPRKGVFEQTFPVTSGRGNVFWIHC ALSMEEENEEGQLIATGYGQRIESPETQGYQCAWNQRINNLLYCQNSIAN SLLKLLSNDTGDELFEEMLADILYFFKGARVYIVRYNWKNGNQSCLYEVA ACNVITLKEKLQNICSEDAPWFYQQIHANRPVILNSPDELPPLAVRDREV LAENGTNSMMLAPLMREEGVWGYMGIDIVDGYRKWNSEDYQWFSSLANII SICMELRIIKERVMHSEKLFHDIFTNIPVGLELYNKEGVLLDCNNRNLEI FGVGDKSRIIGLNLFESPNMTRDIHESLRAGRPGTFHLKYDFDEERRLFQ SERRGVMDLDIRSLMLYDAEDNLSNYLLVNIDNTERNNALSKVHDFENFF SIISDYSKVGYAKINLLDHTGFAVRQWYRNLGESHDTPLADIIGIFSHMH PDDRKSVLDFYEKAKAGTERFFDGDLRIRPADGSDRWNWIHKSSMVTAYQ SPNPRLELVEVNYDITVQKETEAELRAARDKAEESNRLKSAFLANISHEI RTPLNAIVGFSDLLMTVDDPAEQEEFRRTIQKNNTLLLQLFSDIIDLSKI DAGSFEYTPKPVCLYQFCAMMVQKMRNKVSEGVELQIDEDSPLDAWFSAD SGYLNQVVTNFMSNAIKFTHRGTITVGYRIDARQQLEMFVEDTGIGISIE NQEAVFDRFMKVDSFVQGTGLGLPLCKSIIEKMGGHIGVISELGKGSRFW FTLPAFSCIPTR >BF1932 putative transmembrane protein MKQSLTSARRPLEILIHIISWGIVFGFPFFFIDRTGDSINWHAYLRHSAV PLSFVTVFYLNYFLLVPHLLFREQKNKYIIYNILLVCLIGLLLHIWQSLN APAPTLKKPHMPPGWIFFVRDILSLIFTIGLSAAIRMSARWGQAEAARRE AEKSRTEAELKNLRNQLNPHFLLNTLNNIYALIAFDSDKAQQAVQELSKL LRYVLYDNQQNYVPLCKEVDFIRNYIELMRIRLSGNVEVITQFDIQPDSR TEIAPLIFISLIENAFKHGISPTELSFIHILISENKEEIRCEIRNSYHPK TNTDKSGSGIGLEQVRKRLELSYPGRYQWDKAISPDGKEYISKLLIFNHP >BF1878 putative DNA-binding cyclic-nucleotide binding protein MENLKETVDIVVNSRYPEMNREGRELLAQVLIRKELEKGEMLLNEGQISR HMVFVGKGMLRQFYYKNGKDVTEHFSYEGCILMCIESLLKQEPTHLMAEA LEPAVVYMLPYDVLQKLLEQSKEINAFYRKVLEYSLIVSQIKADSWRFET ARERYNLLLHHHPEIIKRAPLSHIASYLLMTPETLSRVRSGVL >BF4171 conserved hypothetical protein MKNLLLFLVFACTFSFSCLGSPVPFSPIVRNYSVLDYNAGNENWAVAQDE CGVMYFGNNSGLLRYDGSRWKLFPLPTSGIVRAVYVASDRRIYVGSFEEF GYFEQNDLNLLEYHSLKEQVKGFDFHNDEIWTIVEQGGNIIFQSFGSYFI YDGKGTKGVRCPELPLNLFRIGDTLYSQLINGGVCTFAGDKFIPLISRQE LGDSDVLAGLPYPGGMLLLTRNSGGYIHTSSGIRPWHTDSDEELKRHTVN RAVMTKDSCYVIGTISNGLYAFSKEGHLLWKENADNQLENNTVLGLYCDM DNNIWTALDNGIAYVRNNSLIYHFEPVRRKVGMVYDVLVRDKDAYIASNQ GLYRLEDTRLELVPGLEEQAWTIGEWGGQVLCGHNKGTFQIKGMQARLLS DVRGAMCMRQAQINGEQLLIQGTYTFLNIYKKSATGEWYFANSVGNFSHM AKNIEVDAHGNIWVQHMRKGLYRLRLDEELKQVTDLKQYDSLSGNQGGNC YLFKVNGRVAFSDGRNFYTYDDMADSIIPYKAMNEQLATLRGIHTVDVMK GDLYWFLSDREAYLVRCTVSDFKVERRIPFSMFGNLPIEGLARMVYDRRN DCSYLCLNNSFARIAADSTGLYKSRQKPSLWVSGFLASDEQTGERIQLPV SGTDEIASAFNNISISLAYPVYNDFALNVRYRLEGLSASGKWTEGLPDLQ KEFTRLPFGSYCFRAEVYDENGVISSVDLPFRILRPWYLSYPAVAVYALS GMALLLGLLYGVYVYTKKKKDAVIERQRARHEAEIEQQEKKIMELEKEQL EADLRFKSKELSGVVMTNIAHQEFLNSLKEELQQQKLSGQYTRKNLDKLL SMINQNMVSDEENWNMFQSNFDRIHENFFRNLKEKFPDLTSGDLRLCALL RLNLPTKEIAKLMNISVRGVDAARYRLRKKLGLPPESSLTDFMIAFK >BF0914 putative anti-sigma factor MEKTKRDSRHIDPLKDEEKFFQWLKFKSVRMNQEHLSKDDYERLRQRIHV SLRMLRRKRTVRRVAYYGVSVCVIIALGIVAYLNHYERVEPVPSVVEKKA EIVWQPLKSEDIRLVSGDSITSFRQNVQLLLSKDGSAMVYHPNSGQKRIR MEQDEVNELVVPYGKRSKVKLEDGTEIWLNSGSVFKFPTHFSGEKREVSL KGEMYAEVTADSKKPFIVHTAHFDIQVYGTRFNISAYEDEPTPSCVLVDG IVGFRPESGPEIRMKTNEKVLYDGKRFEKRKVSASRYTCWKEGYLELDDA NIMDVLNRIGRYYNLSFSFGDKKRLTGRKCSGKIYLSDNIDNVLTTISLL YSTDYRKEERTIFISENP >BF3196 putative two-component system, response regulator MIKCIAVDDEPLALEQLTGYIARVPFLQLIASCQDAFSAMQVLSEEEVDL MFVDIHMPDLNGLDLVRSLVVKPLIVFTTAYPEYAVEGFKVDAVDYLLKP FEFQDLLKAADKARRQFEYHLQDNGGGTETDLLEKDGSLFVKSEYKIIRI NVADICYIEGMSEYVRIYTDTADKPVVTLLSMRKLEERLPQEMFMRVHRS YIVNLRKITEVSRLRIIFNKNIYIPVGDNYKERFTEYINKICVSS >BF1220 conserved hypothetical protein MDLQIIQSKIYEIRGCRVMLDSDLAALYQVETKALKQAVKRNIERFPEDF MFELTKEEVECLRSQIVTLKNNPDEMEAAASSKRGKHIKYLPYVFTQEGV AALSGVLRSPIAIQVNISIMRAFVALRQMITGYQELLKRIEELEESTDAQ FSEIYQALTQLLSKPEPKPRKPIGYRTYDE >BF0692 putative RelA/SpoT GTP pyrophosphokinase MDTENQKEIAEEQMIEQAFQELLNDYLATKHRKRIEIITKAFNFANQAHK GIKRRSGEPYIMHPIAVAKIVCNEIGLGSTSICAALLHDVVEDTDYTVED IENIFGAKIAQIVDGLTKISGGIFGDRASAQAENFKKLLLTMSDDIRVIL IKIADRLHNMRTLGSMLPNKQYKIAGETLYIYAPLANRLGLYKIKTELEN LSFKYEHPEEYQEIEEKLNATAAERDMVFNEFTAPIREQLDKMGLKYRIL ARVKSIYSIWNKMQTKHVPFEEIYDLLAVRIIFEPRNIDEELNDCFDIYV SISKIYKPHPDRLRDWVSHPKANGYQALHVTLMGNNGQWIEVQIRSERMN DVAEQGFAAHWKYKEGGGSEDEGELEKWLRTIKEILDDPQPDAIDFLDTI KLNLFASEIFVFTPKGELKTMPQNSTALDFAFSLHTDIGSHCIGAKVNHK LVPLSHKLQSGDQVEILTSKSQRVQPQWEVFATTARARAKIAAILRKERK TFQKEGEELLNEFFKKEEIRPEAAVIEKLCKLHNMKNEEEFLVAIGNKTI VLGDADKNELKEKQSSNWMKYLTFSFGNNKDKQQEEKEPQEKEKINTKQI LKLTEDALQKKYIMAECCHPIPGDDVLGYMDENDRIIIHKRQCPVAAKLK SSYGNRIIATEWDTHKKLSFLVYIYIKGIDNVGLLNEITQVISRQLNVNI RKLDMETDDGIFEGKVQLYVHDVEDVKAICNNLRKIPNIKSVTRVEN >BF3509 putative response regulator MDIEEIKDFRPLILVAEDDDSNFKLIKAIIGKKCDILWAKNGEEMLNLYR EHTQDAHAILMDIKMPIMNGLEATRIIREEGASLPIIMQTAYAFSSDREN AMQAGASEVLVKPITVSALRGCLSSYFPEIKW >BF0034 hypothetical protein MFNLCNIFQFIILNAPDYTVSDEDIIKFIWKGETSIQINTFCSAGNKLGK RLE >BF1970 possible anti-sigma factor MMEKEQVTRMQNSDLKELLEDVTLNEIHLSNEERQEMTSTFSQIIKKKKR KVQKKRIWSAVAICACVVVVVLGWYSMGQLTVFSAEKEGILVELPDHSVA CLNRNTSLHYNRWGFRFFREVKLKGEAYFDVYKGSHFVVNADPYKVSVLG TRFSVSQKNGQFKAYCFQGKIKVENGKLNSGQILTANQNISVVLGKVSLN IQKELEPVWVRKQCVYENIPLNDVIKKLQEVYGITVLCNRYCDSLRFTGI FPVDDLDLAIQLVFEPFNLECKNVGGEWRLYKNDMKIGRENR >BF2753 putative two component system response regulator MKILIIEDEPSLRELIQRSLEKERYVVEAAADFQSGLRKIEDYDYDCVLL DIMLPDGNGLNLLEQLKKMRKRENVIIISAKDSLDDKVLGLELGADDYLP KPFHLAELNARIKSVIRRQRRDGEMDIRLANIRIVPDTFQVFVDDKEIEL NRKEYDILLYFANRPGRLVNKNTLAESVWGDHIDQVDNFDFIYAQIKNLR KKLKDAGALAELKAVYGFGYKMTVE >BF3755 putative membrane protein MEQREDNKNDIASRRLKNLFGEALGDLSSVEETETAWQAFASRRRQERVR TLVFGFAAVTSVALLLFWGFSQENFLSQEVEVFASVNSPDKLVMTEDKGI IAVRTPPAATITIHLPDSTEVLLNANSRLEYPKAFTGDLRRVMLEGAARF NVQRDTLHPFIVETGSLQTRVLGTVFDVDSYGCGTTSKVVLYEGSVQVSD KANTKACKIKPGEQVYLDRVGDICISQADICMQKSWTEGLFIFDNVTLRY VMQEIGAWYNTNIVFRSHSLLEERIYFSASRHLPVGEILNVLNDLQIARF IVEGDKIVVSPLS >BF3725 putative membrane protein MKIEKEILYRYFNGDATPEEEHKIRQYLEASDENWKEYLRERKFFDTIIL KEQVVSEEKQMKRRQLIRKISLECLKVAAVLLIAFGTAFFWNNQSEKPAT KSVVNTLKGQMANITLPDGSRVWLNSNTRIEYSQHFDDKREVQIDGEAYF EVVRNTGRPFIVYTPDDEQVEVLGTKFYVEAYSGTKKFETALIEGSVRVR AANSQFILQPSYKAVLKGGKMSVEKITDFDIYRWREGLICFKNRHFSEIL EELKKYYGVHIRFDAAKINNPVLTVKFRLSDGIEYALRVLQKDVKFKYVR NDEENTFVIK >BF0470 hypothetical protein MILSQEEKEYFQLFNDMIVALYADNTVEPLKDICRQCIAKEAEIFSSMSK HLEKMRKRNNDIQNAQYLKNLVNGVISMLGNENIVLYDNIEELDVELRRQ IKISLATFKSLDNEFVKNKPIEAICQYIYENSFLKELDARLILGLKKLYS DVNAIGKDDKDVLIIFIKYFLYDMQHKVKYNYINMLIIENQEQPIIEDKA NTLQSFLFYAQRTAGICYKKIVVNEAILLNDDAIVEIEKEASVGSSSSKD ISNEKNKVGIEIDKEKILEKLCPSFNNREQVKKILEKVDERFEISSGECS KLDIATLCLILKEKCSLFNKNMRNFSDFKEYVCLYYGVVNPSYKKNDCIV SKGSSLSRFDELYNDNGAFWNLYLRKNNQF >BF1929 putative UmuD/RumA DNA repair protein MKRIEIHKIDVSSSLPIPYADEGIRAGFPSPAQDYMEQAIDLNKELIKHP ASTFFGRVVGDSMRDEGIEEGDILVIDKSLELQDDDLAVCFIDGDFTVKR VRIEPNAVWLIPANPKYSLIKVTKENEFIVWGIVTYTIKKNRRKR >BF0031 hypothetical transmembrane protein MQKQTVMKRSRLFLWILGILMQAFLISMHFYQRNMEAMYTETEYLLKEVL NEELHRKQLELNMFYVSRIVVDTVPLTIRVTTSEGVKTYTVDLQKSKKNI SQSMAERSWHSIVCMKSCLSTDSLQQLWNERLKKSKIFANTDIHISITHL DNTTSYFKCKTCDDLCFGTHKITFYVGNRCEIEITAFWSYLWQAIYQYNS TPFEVIGIVAAVLIIIFCSWYLTKRYISKIRNDRRRLANDRDRERKVRMQ LEKDQKRLEVKQKEYERRIKDLSLKGEEREEERKSMEKILKEYKMQIQKL KELRESGKEPLLYILSSKVTFDSYAKLLICGDQSISLTSQACQLLDTFLN APEYILTYEELLECLWKDGSGDMIRLRVAISRLRIVLSVDPEISIFQKDI NKYQLVLPEKG >BF3053 putative two-component system sensor histidine kinase MGKSFNIALIVIAVTLYSVTTYAADNKATRHVSALLDLIDNSLNYSKEAP NDSIIQWGNELAPLLKKQKEYKTLFQLKQLIVTAYASRGDMNMAIDHARR MYKEAKELNSPIGIALSSRAIGDAYLNANMQEPAIESYKEALELLDKIPG SEILEQEILPKFILTLIQTSHMDEVRIYLQKFENLYADNPNPTFHFFICA CNAYYNIESGDPEKGKAELDKARKIHEQLNYLYLRSIYNYILAQYYQAVG KYELALQQYECLTKVPKAPAPNKHIGLQLECAQLLTQMGRTEEAYRIYQK ANRQKDSLNALSYARQINDLRGMYQIDRMEIRNQIQRNQIILWIIIASIF ILMLVLLLIVRIRQESNRLLRSKEELEIARKYAENSIRTKSLFLSNMSHE IRTPLNALSGFSSILTDESIDNDTRYQCNDIIQQNSELLLKLINDVIDLS NLDPGKLTFNFKECDAVNICRNVINTVEKVKQTQAGVSFVTSLDRLTLRT DEARLQQVLINLLINATKFTTEGSITLTLEKESETMALFTVTDTGCGILR EKQDQIFNRFEKLNEGAQGTGLGLSICQLIIEQIGGRIWIDPDYTEGARF RFTHPVRPAKEKEAER >BF0808 putative two-component system sensor histidine kinase/response regulator fusion protein MKKLNLFLLVLFICNCPVVSGYAFFDRDIRLLTMQDGLADNTITSIYKDR DGFMWFGTNNGLSRYDGKLIKNFSSSPAYMYVSEIVEMSDRYLGVIAGNT LYCFARSLEKFIPIVHATDYSSVHVSHLLPIDNNSFWGLSGNKLYLYTQE EVKNEKGEVVQIKLKCEKQYKDLIDSGDNFCAMCYTDNHEMLCLVTQQGN LLLFQPESSEKSKKISLWKNKTWDATSVLYDKGVVWVSTIGHGILRYYVS SGYIDRITYKENNKENSLSHTDVFQIIPINNNRYLAVTWSGYTLLFQDKN DPKRMMTEIYYNTASQLHRNLETRMISAYYDPSGIVWIGTNGGGVIYSDL RSQFYNQFHQERHNEICGIVMDNRKYVWMATFHQGIMKSEQPFEPGRRMN FTRVGTPDIQSKNTVLCAINDNRGSLWFGNRDGTLTSYNEATKQFRLHFL QDRGKVNTVSIWALYWDTNRNLWVGTNDGVWKLNIDSGFCIKIPIEILFK DPTPICIRAIAGTKDGTIWLGTSNAGVCKLKIDSRGEMSLETGYEKKANI KNNSVRSLLVSSDGNVYVGYMDGFAILSPKKDAIREYYTTRNGLCSNFIG CLVEDNRGHIWLGSNSGVSRYSRHQHLFYNYYISGSNRSALLADNTLFFG NNKSLTYFDPDDVDGHLDEDQVLITGLEVDGRPVGIGDKINGQTVLAEGI SYTSSITLNNENRDFVLSFNNLSYAEEQQKYNYRLLPYQTHWLVSNDGEK ATYMNLPEGDYTFEVKNIYPDGKDGKVTSLQIHILPHWSRTLPFRLFILL LLAGGVAYLIRLVKHRQMRMEREMRMEHELLSVNLEREKERQIRMERENF FTSAAHELRTPLTLILAPLQELLEHIKASDPLYSKLYTMYKNSSSLHTLV DQLLYVQKIEAGMVKLRLSEADIVELVREVAESFRQMAGIKGCTFQVRLP EDPVFLWIDTEKITSSVGNLLSNAFKYTSPNGEVLLTLTRMEQDGKPFCQ ITVSDTGEGIPDEFQKRIFDSFITGDNSPAFSTKVGIGLRIVKNTMDLHH GQVILDSEPGKGSTFVLLIPEGKSHFTGDLYEIVDYRGHETEPQFQPLSV QEKSEEGVPVTKKTLLIVEDNVDVRQYIRSLFVTKYTVLEAADGEEGVRI ATNEIPDLIISDVMMPVKDGFACCREIRERQETAHIPILMLTAKAEDADV LQGSYSGADDYMMKPFNPEVLKAKVENLILQRERLKRIYTKALMLKRESV EDEEADDEFIQKLIHVVEKNLSNENFNVKMLAEQLHMSQPTLYRKVKQRS ELSVVDMIRSVRVSKAASLIMENRYSIQEISEKVGFSDARTLRKHFTEQF GVPPSKYMENK >BF2840 putative two-component system, histidine kinase MKKIVFLIMCLCSVYANSQEGIPFFVNYPASVYQAHNRNFDVVCDSCGNV YFANFEGILHYDYNRWETIYTPGFSRVTRLFRDSEGRIWVGGYNVFGRIE RDGRGCITLRTLLSDLDTDSLGELEDMAEIDKRIYLKATSGGYYTVQSDS ILAPVQVLPAQLQEKWRNQSSVSMNRAFSLPGGETISINSAHGLIMDDSG KKERFSVTERNGLCSNAVSGIAADGRGNLWGATDNGVFHVFIPSLFSRYT SGEGLKGEVISAVSYKGMIYTGTLQGLYVLKQNTFVPVQGISQACWQLCL SPQGELYAASGDGVYVIRDYNHSEKLTDMAAYSLTFIGHTNLLMGTMDGI YQYSADEERIKKISDVEKVVRLEVKKDRSVWAKTLYGEIYLREEGESSFV LQDRESEEVMTEYTDNDGCHWQTNLKGKEVQVHHSQIDTEKFNQCLYAIR NYVVRVIYIEEDRAAWFGGDFGLIRMDLEKARTFTPVAPRIYLREVCLNR DSVYWGGDLPEESGGADWQINSTVPRLGNDVRSIRFSFATDAPCFTGSNE YRYRLVGYDPEWSSWDSGTVKEYANLSSGTYTFCVRARDIYGTESEMKQF RFSLLPPFYLQWYCLILYTVAFGMLLFLLFKWRMRSLLKEKERLEALVGQ RTKQLVQQKNEIEEKSLKLEKALKELGQAQDELVRQEKMATVGKLTQGLI DRILNPLNYINNFSHLTSGLLKDLYQNLESVKELLDEDTYLDSVDVINMM RDNLEKIEEHGSNTTRVLKAMEEILRDRNRQLEKTELIGLCRKDMELLSS YYQKEITAMHIEVRTSLPDNPLFIDGNAEQLGKTIMSLLNNGMYAIAKKY GKKAYPAEIGLALESKDGQAVIRLYDNGVGIEQSILDKIFDPFFTTKTTG EAAGIGLYLSKEIILNHHGQIAVRSEKDELTEFTITLPLWEEKSV >BF2836 putative membrane protein MQTENFTLGKKELLILLGLTLVLPFPINWALIELNPLTLMAGADDVPTWI GFGGSYIGGIIGGVISIMILNKTLQQTGVLHHDLKLLQLDTIIYTQQQDW FTGFKQELAENLKSIDLYVLNTVVSSISMKNYAYAKEVLTEINKGLEYQM VAASFSFTSTHLSSEEKKYMNLVRRVQTEYSSFIKDILYYIPLAETISSR KKLNYDQLMDYTLSQYDYLQGQEGESTASGAIIPRVMEIDPSDDIRKELE RIMEERLTGRTYLYHLKSDLAEATHQLIIYEENRINSILHKPEREMN >BF4032 putative low molecular weight protein-tyrosine-phosphatase MKKKILFVCLGNICRSSTAEGVMLHLIKEAGLEKEFVIDSAGILAYHQGE LPDSRMRAHAARRGYELVHRSRPVRTEDFYNFDLIIGMDDRNMDDLKEKA PSPAEWKKIHRMTEYCTRIPADHVPDPYYGGAEGFEYVLDILEDACAGLL TSLTQDS >BF2908 putative membrane protein MMEKKLDTFEELMLDFLAGKLSEDGERKLLHFLQSDISYQQRYKEMARTR AKSFIGKFEQEKQADYEALSVKLGIKKKSEKKRIPLWSTFSQVAAIALLI LTTSIAGYYIYNDVAESNQEMALCQMEVPLGSQTKVILPDGSVVCLNSGS VLKYDPAFLRKKNREVYLIGEGYFEVQKNPEKPFIVHADDINVKVLGTVF NVRSYPEDSEIEVSLIKGKVNVFSTSETRDNVILAPDEQLTYDKRSGKMN HHHVDALQTSQWTTGRLSFVNASVPEIMKAIERKYDVRIVIHSKYLDKEV FSGSISPKLTVEEILDYMDVDNKYSWSRSGNVITITDKLIK >BF3855 putative regulatory protein MNKIYIKNMVCDRCIMVVTNILSQLELKVAHIALGEIVLLCPPTEKQMQE LLDQLQKVGFEIIDDKRSRIVEQIKTCIRELVHRKNGMLKTNLSDYLCEN IHLDYSYLSGLFSENEGRTIEKYFIYQKIERVKELLVYDDMQLSEIAYIM NYSSVAHLSNQFKKVTGFTPTYFKQMSTQCRKPLDKL >BF3745 putative membrane protein MNDELEKYFAGTLSATEKTEFLNKLRDNPEAKKEFARMKAVWAVSGLMAQ EGDPQKTVRGIAEFDKRLKRRSVHRFRIGFFKYAAMIVLLISTTWFIANW YTQKEQKKQYTEINVPKGQRVNMTLPDGTSVWLSPQSKIKIPNEFNRKNR MVELNGEGYFEVTKNAKKPFIVKTQLFNIQVLGTRFNVFAYAGKESKFET CLVEGRVLVYNKNNKNEKVYLNPHEKVSLVNNRMVVSTSNFDNEEYLKSG IFSFRSKPFGEILSYLTLWYNVQFNFTGDVKLDERISGKIRQSEDVDNIL IALQGVYPFKFKKTDDEHYEIY >BF0030 putative AraC family/two component family regulatory protein MKSILTFLLIILMDIQLNYACPCSPTNTFIEMNESFASQFQTATIIPMFL WQSSWSYPIEGLAIGLLISLIVYYRMVYSTKLFPHEKLRLILNITHKTQT PLTLIHHLLEEIISDSLSESTSQKIKRILGYTSHIMSCYQNIAVFDDKEN ELHPGSSPIEFELYTFITSIVNQCRAYADTRQIKLNINKDFSYISCRMDE ITMTAALQCLLNKMIEATPCKGCINMDVSHSIKHWNLQITNGPECRQSHK KILSFISTFMLIHYCGSLQIIKKIIRLHGGKLIGSYHGRSITLRVTVPIN GYCNTIQCPEVVPPVMKDDKIIRPDKKQHHILLVMADTELSNYLHKAFSI LFRITILENPEQILHFSGDRLPDIIVIDETVNGIRGKEICSKIKSNTSMV HIPVILLISNNDNGSYLAHADCGVDKLEPRAINICRLKMDIQILINKHER IMKLLEKNLSDNLPSPTAKSEEDTLFINKVNKLLEKNLSTESYTVDMLSA DMGMCRTKFYTKIKEITDKTPTEYMHYFKMNKAKILLVTQQYTVTEIATF LGFCNAKYFGKRFKKFYKVPPTQYIKEVF >BF4103 putative two-component response regulator autolysis regulator LytR MAVMKVLIVEDETAAYENLTDILTEITPDIRIMANTESVTQTVGWLQSNP APDLIFMDIHLSDGSAFAIFDRIELETPIIFTTAYDRYAIEAFKVNSIDY LLKPVKVEDVEHALEKYSKLTRQDLLQYLSQLTLLKPAPRYKDKLLIAHK DKLLPVNIKNISYFYATGKNTYVCLKDGNRYPYSKTLEQIASSLNPEDFI RANKQFIVARDSVTDITIWFDNRLLITLDTEVPERIYVSKNKASEFKTWL VNDK >BF0584 conserved hypothetical protein MPSHSKRNSDVDMQALLNDIELDIQELKYLMEIISREPDSVLRGVARRNI VQMRGRLDALLELLDAKPVIAADASESPENRPVTETIEVVEIPALKETVA DIPEKNEEAAVAEDSQEAVEPGPLSLSEAVIEQVPTVELDPVADEKEEVF ESVSVPQSEEPTVKVETRVASSPILAERIKTAGDLRRSISLNDSFRFSRE LFGGSMEQMNNVLHQIGEMSSLDAALVFLSSKIKVDEENEAMNDFVELLR KHFI >BF2686 putative DNA-binding response regulator MKNNESIRIAVAETSVIIRSGLTLALKRLPNLKIQPVELLSVEALNDCLR TQFPDILVVNPTFGDFFDVARFREETAGKGIRVVALVSSFIDASLLSKYD ASFSIFDDLEALANKINLLQNIEPEEEEDSQENLSQREKEIVICVVKGMT NKEIAEKLFLSIHTVITHRRNISKKLQIHSAAGLTIYAIVNKLVELSDVK DL >BF0902 putative transmembrane and transcriptional regulatory protein MDIHPIQESSRRWMTALILAVVAAGIQTTLLWGYAGADTLPAAIDGILSV GLLCLLAYLAWYVIGLVSILQTDLLIAALALLFWLAGGFAVQYVLEQNMG QVYAPFGETLPFRILFGALAWGVMMLWYRLQSLNTVQEEILEEAVSREEA LREELRQIECREDKALPEEAECIDRITVKDGTHIHLIRTDELLYIQACGD YVTLVTPSGQYVKEQTMKYFDAHLPSAGFVRVHRSTIVNVTQISRVELFG KENYQLSLKNGVRLKVSNSGYKLLKERLEL >BF2789 conserved hypothetical protein MKKREFKISFFLHVWEKKAEEISLEEFHNDLRGARWKVLAESYRRWMRTG MTEEGKRLKGALNAVVVAGKCRGGHAANQVTELNGLALFDFDHCLEMLAG MKEKAGALPYVVGAFVSISGEGLKLIVRIDAENAGQYAVAYPVVARELER VLGHPCDMSCRDLGRACYASYDPEAYYNPGAGVFPWREQVDGLLQAEGEC SAQSVGKACLAGVASEAGDGFMQVFLNDFDARNPFVAGGRHAFVLKLGRV ARYKGFSPEEMRLLQKAVVEKYAQADFGSGEIEKTLSSGYQYVSARRADA MTTDLGPKVQGPFYGMPEEEEEEDLEDILFGKSEGFRRSAPYFPDEVFEH LPALLAEGVRVAGSPRERDMLLAAMIVNISACLPEVRLLYDQMYYSPHLY YMVIAHAGGGKGVVGLAGMLPAEIHKFYEKQNDEVRLVYDKAFFEWELEQ KKAQAEKRSPDFALRPREPLRKLLMLSPNVSKSLIISALEESGKLGCCIN ATELDMVSGAIRNECGKHDDVFRAAFQHEVVSADFKVNGRQVVARHPRLA LCLAGTPNQLVRFIPSLENGLYSRFLIYTGQSAWEWRSAAPRAGCEDHRA VFARLSARLLELHQFLLQSPTEVTFTPGQWEEHTLRFASHLSEVVNERDD SPGAIVLRHGLMASRIACVLTVLRKGECAWAMPEYACSDEDFHTAMLMTD VLLEHSLLLSTCMQKSESKPKPLKPYFRLRPVLQVLSGTFTFTQVVDKAV EMGIPKTTAKRLFRKTVELKLVVKEGDVCRKTTRSWGAGIP >BF3197 putative two component system, sensor protein MKQINKQKLLEQMVYLVIWLTVISVPLVGDYLFASISPVHTFSWQTIRVA WLLTLPFILLFVVNNYFLAPRLLLRKRYWAYALSLAGVVTLLFILYPSIN PPQHKQFQNLMPMQPRRYPEGKVLPDREREFPNTFPEHSSPLLLPKQELD MRWRGPHPLPGYFLGRLSLALLVVGINVAIKLLFKSMRDEEALKELEHQH LQSELQYLKYQINPHFFMNTLNNIHALVDMDAGKAKRTIVELSKLMRYVL YEASNRTILLSREIQFLDNYIALMKLRYTGRVRIECCMPDEVPEVQIPPL LFISFVENAFKHGVSYQEESFIRVFMSVEDGRLAFRCSNSNHGRSVEQHH GIGLENIRKRLRLLFGQDYTLSINERDDSFNVLLIIPLL >BF1203 putative anti-sigma factor MTCEEKKDLFDRIESDEALKKEFLRMQNVVALTQILSRQDDSETSRKGKQ HFMQLLFRKRLKRAITVSLKYAAVFAVLVVGTFYTAKLYLSEEFGKSYTI VTAPKGQRVKIELPDGTIAWLSPCSRLRFAASFNETDRKIELDGATYFDV AKNPEKPFVVSAKGYRIRVLGTKFNISAYKNSKEFETDLVEGCVHIYDPA DIRNEVFLQPKEKAVLWGDRLMKRESDFDNEEYLKNGVVSFLSEPFGRVL NSVALWNDVNIKIERSVNATQRISGKFRQSDSLESILKALQGAMPFKYKI VSEEEIIIY >BF0335 putative two-component system sensor histidine kinase MSLEKERIEKEHIEEMNQAKLRFFTNVSHEFRTPLTLIISQVELMLQKNT IPPSLHNSIFRIRKHAQQMKLLISELLDFRKFDQNYIQLKLSEQSLNTFL EEVYLSFSAYASQKSISYHLKLLEQDISIWIDDWQMRKVLFNLLSNAFKH VPDKGEISILTSTTPDQVVIAVKDSGNGISKEEQERIFDRFYQADNRNKA IHVGTGIGLALTKSIIQLHHGTIEVESELNEGSCFIVKLPKTRDCFEKDT EVVFLESPEKEPMVQENTIPDENFMKKDDSTFETPLIDEREGKRKVLLVE DNVELLQVLKEIFSSLYQVVTAANGEEGLKQAFAEVPDLIVSDVMMPVMT GTEMCLKIKNNINLCHIPVVLLTALDTVDQNIEGLRRGADDYITKPFNAK ILITRCNNLIRNRLLMQSRFAKDQILEINLLAANPIDKGFLDRVIKVVDK HIDNEDFDIGMLCQELGMGRTLLHTKFKALTGMTPNEFILNHRLKIASLM LKNEPYLQVAEISDRLGFGSPRYFSRCFKNQYNVTPMEYRKGAKQENLK >BF1605 putative two-component system sensor histidine kinase protein MIFSQRIYFIILFHVLLILVTAGTGLWLVVSHTGYIIGGILLLCSLFQIG ALTRQLNTFNRKIRLFFDAVQDKDNMLYFPEANVGKEQAQLNRSLNRLND LLARTKGESHKQEHFYQSLLEEVPSGVLAWDDSGRIIIANSAAFSLLKCN RLYTETQLAQLLNATGIRKSLSISEKKMILDGETITILSIKDIGDELSDK ENESWSKLTHVLTHEIMNTIAPILSLSQTLSERPDINEKSARGLRIIQAQ SERLMEFTESFRHLSYLPHPEKRRFALTEMLRNLEELLQSDFRERGIRFM LQCVPDPIETDGDPNQLSQVFLNLLKNAMQALEGQADGRIILRVRRADRL QVEIEDNGPGIPEEIREQIFIPFFTTKTEGSGIGLSLCKQIIRQHDGHLS IRESRPGQTIFSLDLP >BF2943 conserved hypothetical protein MIVGGLWMHLNEGSTPMDKYIEITAQKSRMYLLPDSSKVWMQPGSSIRFA EDFKKHRNVWLKGNSLFEVHKNMGRKFRVYIDKAFIEVKGTCFLIKQNNP SANEITLFNGSIEFNVESTQHKIEMKPLQELVYNPADAGTQLRQIENIEW QNGRYNFTQFNLEHLTRIINQMYGSRIIISDKVNKNCAFTGSIRYDESLE DVIDKICFSLNLRKKEINHEIIIYN >BF2629 conserved hypothetical protein MKKTLTVNLGGTVFHIDEDAYRLLDNYLCNLRLHFRKQEGAEEIVNDIEN RISELFAEKLSAGSQVITIADVEEVIARMGKPEDFGEDTGEEEPQKTTGQ TGVQQGATIRRRLYRNPDDKILGGVISGLAAYLNWDVTVLRLIMFVVLIC GYGVLIPIYIICWLVIPEARTAAEKLNMRGEDITIENIGRTVTDGFERMA NGVNNYVNSGKPRSFLQKVGDALVSIAGFFLKACLVVLAIICSPVLFVLA IVFVALVIAAIAVAIGGGAALYQMLPSVDWSPLISTSPMMTIAGSIAGVV LAGIPLAAIIFVILRQIFNWSPMSSGLKWSLLIIWILAVVIFVINLSYLG WPYPFLWVG >BF4312 putative two-component response regulator MNKINVAIIEDEIPAARLLHSMVSGLRPQWELTLIPGSVDEAVAWFDEHP HPDLIFLDIHLADGNAFDFLSAAHPSSVIIFTTAYDQYAIRAFTVNSIDY ILKPIDEKRLSDAITKYESLLTNAVPRPEDYLGTLLEALQYKEKRYRTRF LISGVDRFWSLQVADIAYFYSENKVTFAVTRKGQEHILDLSLNKLMEQLD PERFFRANRQVLVCIDAIDHAEPFFNGKIVVTVRPPYKQKITISEEKLSA FKLWLNH >BF0165 putative two-component regulatory system, sensor kinase protein MKKELLLTILSSIALILLQVFWINSMYQKYENQYTEKINKAFFNAIEKEV GLRSMHIEQSKHSTIFIKSVEYMSEEERAGYKGDTIDLVHLEQNGVARNV SELLTQIKQDGLLAIQKPPILSIIDSLFQDELYDLNINHYITLRNKEKQI IDSVGNAHLQSHFQIIINQKPIGTKGLLYIQIESGLPNDTILSQMLYSLI ASTLIVAIVLGCLIFQLTVIRKKNEILKNREASVNGIVHDLKSPLNALIT LTCWLKKNESDHKKKQLMNEVIKRAKHLTTQIESILICARGTTQHIILQR TKINIEEVIKTAIGNICVDLSSKPHSIEIVNESPNIECLADQLYIENAIK NLIENALKYSNDGVKIQIKIVKISQGIQIEVKDNGWGIAHKYQKKIFSQY YQVPRETSQIQKGYGIGLSYVKYIIQAHGGKIRLRSRENEGSTFTFYISK >BF4048 putative two-component system sensor histidine kinase/response regulator fusion protein MHRNTALLIIVILLCASSALGRGVNYQFTSISIEEGLSQSTVQSILLDKK GKLWIGTRNGLNSYTGQDLKIFKSNPEDRYSLPDNEILHLTQDSLNNIWI STREGMVTYDEKHGNFTLVNRDIIYSSLCITDGILFGSENRIYKYDYKKR SFKSINIKKQEDKGSDVTKYRVQKIIAFSEREALVATRRDGVYVLDYQTM RLKRLFSGSNNILQGAYLSSNGYIYLSFWGQGLFCYEKTGKFIKRYTKEN SDLTNNYVLDIVEKEGFLWLATDGGGINRLELSNENFSNLYHIAGDKNSL PVNSVTILYKDENEGLWAGSVRGGVFNIKESYIRTYKDCPLGYINGLSEK SVTSLFEEPNGRLWIGTDGGGINLYEPQTGDFKHFYSTYGDKVVSIAPIS EKELIVSVYTKGLFLFDTHTGAYRPFLIINDSINFRQCFYGYIPRAHRVT KNKIYILSKDIWIYDINNRKFSPIKTDKNYQLPTSVMGYSDEKMSLTMSG NKVFQIINKNDSIQPLFQIDEKETITAIDCDGQDRIWVGTTAGIGYYNLK EKRYSKIDSQLFSDISALRYDPSSERVWICAQNQLYSYCIKDDKFIQWNR SDGFHPNEIIFTYQQRTMKKHRYLYFGGIEGLVQINTDIPEPNEPYPEID LCGVELNGQLQTSDINIRNIKIPWKYNTLILQVHIKNKDIFQRVPFRYII KGDVDKSIDSYHPMLELSNLSPGKYHIEVSCMTKDGNYTMPIHLTDIHVT PPWYKTDWFIILCCIFLTGGIIVGMSIFNIRKEVKIQKRLKEYRQYFNEK KIDFLIHINHELRTPLTLIYAPLKCLIDKNETQGLPSYLMPQLQLIFNQA QYMREIVDMVLDWNSMEAGYSKLKIQKCKLDEWITNIVKDFTEEARQKGI CIKLQMTTDIEEVWFDKQKCHTVLSNLLMNALKFSMPESCITINTRKLEN KVRISVVDEGIGIQDSDITNLFTRFYKGNHKEKGSGFGLYYAKTIMEMHG GDIGTYNNTDKGATFYLELPLLDINEKAEATKLLQKEAPIVNTTQDLHFD CTGKTILIVEDEKELREYLIESFTETFKKVYAADNAISALETCRKKQPSI IVSDVMMPQMDGFELCRQIKNDIRISHIPVILLTARYDQTGITTGYKSGA DSYIPKPFDLAFLKVVVGNILKNREKIHSQYVTVTGSLSLLDLTNSKADE DFMKKINAVIHENLSDEEFSVQQLADAMIVSRSSLYSKIKIITGMGVNDY INRLRIEQAMSLLVNTNLNINEISCEVGFTYPRYFSSTFKSMTGMTPKQF RNEKCNK >BF0040 hypothetical transmembrane protein MTKNKLLSCVIGVIILSLLVGAYFYQRNKVAVHQQAERLFVQMLQEEIER KERNLNLFHLFSESSSDTLPLKICIITEEGKKEYEVDSLKSKKNISQNLR NRSIHSILCEKSHLLPDSLNEHWQSMLKKDHIDTESTIHVRMENLQGKII SSSSHDGVWDTSSGIITSYIGNRCEIEVIGLLAFSWKTILWYHWQPFGWI VICLLLMLLFICFYYKKVNRPPELKEVPYEVVVEKEVVVEKEVIREIIVE KETSPEKKAPLIKQICKVEGQLYGLRYGVVFDSQNRVLNCNGKKMSLSPQ QCQILKLFLDAPDYTVTDEDIIKFIWKGQSNVQINTFCSAGNKLGKRLEQ AGCGVCFRRFGSDRYRMLFIDDLVDNDLT >BF0276 putative two-component system sensor histidine kinase/response regulator fusion protein MRIITLLITLFAFGITPLQAFSYFSFKKYQVEDGLSHNTVWCAMQDSYGF IWLGTSDGLNCYNGRGNKVYRNVLNDKFSLENNFVQALFEEENHNIWVGT NWGLYIYDREYDRFTYFDKKTRYGVFISSEIKKIIKSESGLIWIATLGQG LFVYNPQTDVLTQNSLQTSFVWDVCENNSGHIYASSLQEGLLCFDENGKF LQSYPLLSAGNNPDNYRINCLLDIRSDIWFGAGSNLLYCLNERTGNLDCY NASHLNFGAIRCLLNYSETELLVGTDNGLYLFDLHDKNFSRIDNPSDPRS LSDQSINAMMRDAEGGIWVLTNLGGVNYLAKPTKRFDYYPPVYRDGGVAA GKVVGPFCENAAGDIWVGTRDGLCFFDVSTHQLTAYPIGGGVDKKYDIRS LLLDGERLWIGTYAEGLKVLDLRTGHVKSYNHLQDTPNTICSDDVLAVYK DRSGDIFVGTSWGLCRYNPREDNFSTITTVGSMVSVVDILEDMYDNLWIG TSNSGVFRFNTRNGHWKHFQHERNDSTTITNNSVITLFEDLKGTMWVGTN GGGLCSFDPKTETFIDFDPDNTILPNRVIYSIEQDKTGDFWISSNAGLIT INPITKQHFRQFTVNDGLQGNQFTAQSSLKTASGKLYFGGISGFNSFVPD QFMDNQYIPSVYITEIRLPYTTDERLVQDILHLKGPLYRAETITLPYEHN TFSVSFVALSYEDPLKNRYSYRLKGVDKEWVINSEQNTASYTNLPPGKYE FEVRGSNNDHKWNDQTTSLLIVVTPPWWLTIWAYCVYTLLLLGLAYYAGW HWNRHVKKKYKRRMEEYQTTKEKEVYKSKISFFINLVHEIRTPLSLIRLP LEKLLEDKREGRDAKYLSVIDRNVNYLLGITNQLLDFQKMENGGVQLSLK KCDINQLVSDVHSQFTSPAELKGISVMLDLPEGEIFASVDREKVCKIIVN LIGNAVKYAQSRIDIKLVSSDEGFRVSVSDDGPGIPDVEKRKVFEAFYQV KDGKSGAVGTGIGLAFSKSLAEAHHGTLSLEDSVYGGSSFVLTLPWGEEA VSEEPEVVIPDGREAADEEQGTELSGSKFTILLVEDNVDLLNLTRESLST WFKVLKAQNGRQALEVLANETVDVIVSDVMMPEMNGLELTAKVKSDIEYS HIPVILLTAKTTLEAKVEGFECGADVYIEKPFSIRQLRKQIENLLKLRQA FHKMMAELSGGNGAAPISPVEYSVSQKDCELMAKVRAAVEAQLSDENFSV DTLAESLNMSRSNFYRKIKALAGMPPNDYLKTIRLNKAAELLKSGVRITE VCEKIGFSSSSYFAKCFKIQFGVLPKDYH >BF2174 putative AraC-family transcriptional regulator MADNVKANKMNSQADDDIGFGIYTDIADLPMTGCPSYIEEGIGGVCESGT ATIVVFDVPFQIVPNVVITLMPWQLVFIKEISEDFRITFFKISKDMFSET LSTLWRPASGFLLYMRKHIVSIPDGELIGRFLAYCNLLVYRMKHTPQNCR QESIMQLLRVYFWDVYTVYINDPQAEKSLKFTRKDEYVYQFVRLIIEDHS PDKDVAYFAQKLGISPKRLTNLIRSISGQSAREWIVYYTILEIKSLLRES SLDIKSIAARVNFPDQTTLSRYFRHYTGVTPSQYRKNIYF >BF2241 putative two component system response regulator MAKILLVEDEVNIASFIERGLKEFGHSVSVANDGDAGWELIRQEAFDLLI LDIIMPKMNGLELCRLYRQQYGYLTPVIMLTALGTTEDIVKGLDSGADDY LVKPFSFQELEARIKAILRRGREDSVQQLVCDDLVLNCNTRRARRKEVEI ELTVKEYRLLEYFMTHQGMVLSRLTLLKDVWDKNFDTNTNVVDVYVNYLR GKIDKEHDKKLIHTVVGSGYIMYA >BF4110 putative transcriptional regulator GerE, LuxR family MFYDYLCKGKSLYLSTQCLLITISFPDMDIVDKLNKEFLTQPFCKNEQLP EELNEYKRIAYNYARIENSIAVLSDMHTNISYIYYGGTAETLGIARKGDN QNLESIWEKEVFKYIHPDDLVEKYVQELRFYHFLKQIPHKKRADYFLMSK LRMRDPSGKYIPILHRMFYVATHSNDSMWLALCLYNLSVDPTMSCRVINS TNGQVIELEKQDCSRLLSDREKTILQLIDMGKTSHEIARELFISKNTVSR HRQNILEKLQVKNSIEACRIAKELKLLF >BF0101 putative two-component response regulator MYKVIIIDDEKAAIETLRRDLEVQTDLEIKGTAGNGAKGKKLIMDIHPDL LFLDIELPDIQGIRLLSEIREQVLWDMKVVFYTAYDKYLLQALRESAFDY LLKPYDIEELNLIIERYRKTMASARPLPSFASAVGTLMPGRDLFMISTVT GFRFLRLEEIGYFEYLKDKRLWQVELFNQTKLCLKKNTTAGDIIGYSDAF VQISQSAIININYLAMIKSKQCLLYPPFSDKEDLIISRGFLKELQERFCI I >BF3850 putative regulatory protein MVLIVEDDRTYAYTTANWLKKHSIDARYVLSVDKAKLFLYHNEVDLILSD FRLKESNGIELLEWIKAEGYQIPFLIMTGYADIPGAVSAIKKGAEDYLPK PIQTEKALSIIQEVLERNRKDSKTKQAFYIGQSPLSLKLQHYVRLVAPSD MTVLIRGASGTGKEWVASQIHALSGRANAPFVVVDCGTLPKELAASELFG YVKGAFTGAVEDREGMFARANHGTLFLDEIGNLNMHVQMLLLRALQEKHF RPIGSWKEIEVDIRLIAATNEDLEKAIMEGRFREDLFHRINEFPLQVPLL AECPEDIIPLAEFMLNIANRELNKEVKGFDRETQKKFKSYSWPGNIREIR MVVKRATLLAQDDWITMEDIELLPNKHPKEYTLKDERVERNNIIKALNAT DNDRTATAQLLGISRSTLYLKLKKYRLI >BF2954 conserved hypothetical protein MRSLELFTLLLFKQKRYKLYMKQEKFFRLLPIEGAYNIRDLGGYPTSDHK HVKWKTFIRSGDLDKLTESDLDYLTSLHIRTDIDFRSMQEKKAAADKIPS TVTQYIPLSIEAGDMTDMAHFNLNNIPGILEQAYVYIIQNAQDTYREFFR IVSEERNTPLLFHCSAGKDRTGIAAALLLGALGVDREVIMEDYMLSAEYI KGKYDAIVQAHPGFAPLTTVRKEYLEATFQTIDTDYQGMDNYLKNQLGVD THRLRMLYTE >BF0782 putative two-component system sensor histidine kinase MASMAQLGWWEADFTAGHYVCSEYLCDLLGLEGNTISFTDFRKRVREDYQ EQIVREFNASIHREFYEQTFPIHSKEGIVWLHTRLGEREEIPGRGVVSFG IMQRVEAPNDTSERVLERVNDLLYRQNSISHSLLRFLKDDSVDLCIMEIL KDILDLFHGGRVYIFEYDEYYRYQDCTYEVVAEGVLPEIDSLQRIPTDSL PWWRQQTLSGKPVILDSLDQLPKHAKAEYAILSRQNIKSLMITPLIAGEH VWGYMGIDLVKNYRNWNNEDFQWLSSLANIISICIELRKAKDEAVRERSF LRNLFRFMPMGYIRMTMVRDAAGLPCDYRIADANDLSSELIGMSLSDYVG CLASELHADFKAKVDYLLDVMEGSVHKETDVYFHRTQRSSHCIVYSPEKD EVVALFLDSTETIRAHRALDRSEKLFKNIFANIPAGVEIYDKDGNLLDLN NWDMETFGVKDKADVMGVNFFENPNVPLEIRERVRNEDLVDFRLNYSFNK ASDYYHSDKSNIIELYTKVSKLFDSQGNFNGYVLINIDNTERIDAINRIR DFENFFLLISDYAKVGYAKLNLLSKRGYAIKQWFKNMGETEDIPLSSVVG VYDKMHPEDRQKVFDFYEKVLAGEEKDFRSEMRILKPGATNEWNWVRMNV VVTKFEPEHGEVEIIGINYDITELKETEAMLIEAKEKAETMDRLKSAFLA NMSHEIRTPLNAIVGFSGLLVDTEDMEERCEYIKIVQENNDLLLQLISDI LDLSKIEAGTFEFTYGETDVNMLCEDIVRSSQIKVPQGIELVFDPHPSDC TVISDRNRLHQVISNFVNNALKFTSSGSIHVGYEKKEEGVEFYVSDTGIG ISKEQLTHIFERFVKLNSFIHGTGLGLSICKSIVEQLGGVIGVDSEEGKG ARFWFTIPYINSEQSIVND >BF0135 conserved hypothetical protein MYKNLFNLLTILLILPSCTDMSPNISVVCEENNIGNCILKWETTPLIKGQ VKVYTSDNPEFIPEDNPVAMANISDARMTIVTNDPSRRSYYMLVFNDKYR VKVAPRNVNMPGIQNFRDLGGYKSATGKHVRWGKLYRSAQIDSLNCFALR KLQNLGIKTILDLRSESELHNTPPLQKGFNVVHIPINTGDMEHILHGIQQ EKIKTDTIYHMVEAMNRELVAKYQKEYKEIFDILLDKNSYPVVIHCSSGK GRTGIVSALILASLDVNADIIMEDYRLSNDYFNIPKASKYAYNLPVNSQE AITTLFSAKEDFLNAAKDEIERKYGDVPTYLRKAIGLQSEDIHRLRTILL E >BF3155 putative two-component system sensor kinase/response regulator fusion protein MKKILFLLLLLPLMVSAQTYKYIGVEDGLSNRRVYYIQKDKKGYMWFLTH EGVDRYDGKEFKRYKLMDDGEELNSLLNLNWLYLDHESTLWEIGKKGKVF RYDPLRDQFTLVYKLPEEKIKDRPAPISYSFIDRNNNIWLCNEETLYLYN THTLQTLQIKNEIGEDITDIEQIDDTHFFIGTEQGIHHAELKNQGLHLLP CDKLDNLPIQINELYFHRPSRKLFIGTFERGIYVYDMNTKQSTQPHMSLT DVSITRIKPLNNKELLVATDGAGVYKININSYLTTPYIVADYNQYNEMNG NNISDFYVDDEQRIWLANYPIGITVRNNRHSSYNWIKHSIGNKQSLINDQ VNSIIEDSERDLWYATNNGISYYNSETGVWHSFMSSFEKNGGNKNHIFVT LCEVEPGIIWAAGYSSGIYQINKRTLSVEYITPSSLYGVNIRPDKYIRSI IKTADGDIWSGGYYNLKRIDFHKKTLRLYPKLNSITSIMEKDSKQMWIGT ATGLYLLEKESGKYQRIELPVESMYIYSLYQARNGLLYIGTSGSGLLIYD PEKRTFTHYHRDNCALISNNIYTILSDTDDDIIMSTENGLSSYYPAEKLF HNWTKDQGLMASHFNAGSGTLRKNGNFIFGSSDGAIEFNKEMKIPRKYSS KMVLSDLTIFYQTVYPGDENSPLSTDIDDTKELELSYSQNIFSLKVSSIN YDYPSNILYSWKLEGFYDQWSRPGNENIIRFTNLSPGEYTLHIRAVSNED KRIVLEERTMKISIAQPIWLSFWAMLVYAIVLAVIAIITLRIIILRKQRK VSDEKIHFFINTAHDIRTPLTLIKAPLEEIREREALTKDGISNMNTALRN VNALLRLTTNLINFERADVYSSELYISEYELNTYLTETFNAFRPYASVKH INFTYESNFRYLNVWIDKEKMDSILKNIISNALKYTPENGSVHIYASETN DSWNVEVNDTGIGIPANEQKKLFKIHFRGSNAINSKVTGSGIGLMLVWKL VHLHKGKINLSSVEHQGSSIKVSFPKDSKHFHKAHLATRTRELSTEQVPH VSPAEIYEKAKKQHDQNLQRLLIVEDNDELRNYLTHTLSDNYTIQTCSNG KEALTIVKEYMPELIISDIMMPEMRGDELCAAIKNDIETSHIPIILLTAL NDEKNILEGLKIGADEYIVKPFNIGILKATIANLLTNRALLKSKYANLEV SEEEEVSPNCATDLDWKFIATVKKSVEENIDNPAFNVDVLCNLLNMSRTS FYNKLKALTDQAPADYIRLIRLKRAAALLKTGQHSVTEISELTGFNDVKY FREVFKKHFKVSPSKYCKEGGKEDVEEQQE >BF1963 possible anti-sigma factor MNRIEKNKTQTDQAWNKLHNRLETDGLLPTVTERRFATRPTAWIGIAAIA AIISLCVYLPTVLRTDRHLSGGELLVKANKEESILVTTLEDGSVVYLSEQ TSLEYPKHFSKKRREVSLKGNALFDIAGNRARPFFIETGKVQIEVIGTAF HVRNSGNSPFELAVQRGEVKVTQKQNGQEIHVKAGETATLLGDEWQLTVT ENSEQFTRYMQNMRFKDEQLDHILHAINLRQTEIHLQSSPELGKHVLTVS FSEDSPEKMAELIGLALNLKCTRNQNIITLSE >BF0486 putative two-component histidine sensor kinase MMIYIIFRVFIIIILFICARYWYLWRKISVQKNEWVAQTKESDTILRSMN ACFILINSDLVVIRTNYYDLSGISEEPESSGRVGDLLNCKNAVRSGGGCG AHKNCENCMIRHTIENAFCHKKGFHKLEASMRLLSSDHQQIIPCDVSVSG TYLNNEGHEQMLLTVYDITELKNMQRLLNIEKENAVSAEKLKSAFIANMS HEIRTPLNAIVGFSGLLASADDDTEKKMYLDIVAENNDRLLQIVTDVLDL SKIESGSLDFHYSEFDVNDLLCALHGILNIRLKDKPEIKLICKAGTDEWI IYSEQHRIVQIITNLVHNAMKFTHSGEICFGCRPQGEDEIYFYVSDTGIG IPAGEQDKIFDRFTKLDHEVPGTGLGLTLSQTIVQNLGGEMGVESEVTKG STFWFTLPLKS >BF0183 conserved hypothetical protein MTKRLTKIGVNPDFQELSSFVHELPTVFETGGKVIYKGRNELKEFDVEGK KLIVKSYQLPHLLNRIIYNFFRASKAKRSYSYALMLRKLGIGSPAPVGYY STGSWLLFGRSYFVCLKSDCPYTYRDFEKTVFPNQEQILRAIARTTAMLH ENGLLHKDYSAGNILFRTIDEKVEVEIIDLNRMRFGNVGIEAGCKNFERL PGTHEMFAILAEEYAKARGFDVQTCLELIEQAHSLSD >BF2842 putative anti sigma factor MTLLQFRPVDGRLDEILSMLMHSREVASHPSLSYAIRLVSEEIIVNILNY AYPQQAEGYLTLCLWDEDGEITLEFIDGGIPFNPLDKADPDISLPLEQRE IGGLGIFLVREMMDDVAYTYVNKENRLTIKKKYLQPTDEPVS >BF2095 putative two-component response regulator transcriptional regulatory protein MSCQSTYYTMTLKRGKILIADDNEDILFTLKMLLRPIAESISITTDPREL LPILSRTHYDVILLDMNFRNDAVSGREGFHWLEEILKLDSGAVVIFITAY ADTEKAVRAIKLGATDFIAKPWQNDKMIATVSAALQLSFSRTEVESLKEQ KEALTAPSPEPARIIGESAAMQAIFQTIRKLADTDANLLLLGENGTGKDL IARYVYEQSPRKGEIYVPIDLGSIPETLFESELFGFEKGAFTDARKKKPG RLEVASGGTLFLNEIGNLSLPLQAKLLSVIEQRKSSRLGSTTSYPVDVRL ICATNTDLYTAIDNGLFRQDLLYRINTIEIRIPPLHERGNDLFLLADHFL QRYRKKYKKEVRGISKEARRLMQLYRWPGNVRELEHAIERAVILSGNPML MPDDFMLRTSPQGQVSEKEKYNLERQERETISEVLRLCAGNITLASEMLG ITRTSLYRRIEKHGL >BF4150 putative two-component system sensor kinase/response regulator fusion protein MMWQIVLSLVCVAFLGAILWEKRQGKLMQSASDRKLENVNCLFDAILTHI HAYVLVIDSDFKVLKTNYYDLTHLSPDGKEKRVGDLLQCRNALSAKGGCG THAFCQECPVRGAIGNAFRQKKEFTDLQSSLNIAIDEHEFVKCDVMISGV FMTLDSEERMVLTVHDITSIKQTEEALAEAKEKAENADRSKSAFLANMSH EIRTPLNAIVGFSELLAAANTEEEKQKYLEILHTNSELLLQLVNDILDLS KIEAGTLEFVYSDVDINLLLNDLEQLFRMKIGSNSPVQIITESGLPSCMV HTDRNRIAQVVSNFVSNAIKFTTEGSIRIGYQSSENGLRFYVSDTGSGIS ADKLEGVFDRFVRLQSDKNGNGLGLSICKTIVNKLGGEIGAESEVGKGST FWFTLPEHSDIKPKVIIEKEQEELPSAVRVPVIDAGSDKKLSILVAEDME DNYRLCEAILASRYELHWAHNGEEAISLFLKFQPDIILMDIRMPEVNGYE ATEAIRQMSATVPIIALTAFAYEEDRQKIMHSGFTDFLTKPISSKVLLGK LESLKKI >BF1489 putative conserved TraI-like protein found in conjugate transposon MKKLFLSLIVMMTAATASAQWAVTDAGNLSQNLKNFKELQKQVGYLQQQK KLLDESLDMMRKVNSVVSDCETTRYIIERQARLSQKCVDLLSGKQLNSST LQTLTGSIEQIMAGNRRLIQLSRTILSTSVRMNDAERLSTLQNIEKQTLE EERKIARISQVINQYERLKRALR >BF3435 conserved hypothetical protein MLSKFKLNQLYFKDTQFANLMTRRIFNVLLIANPYDAFMLEDDGRIDEKI FNEYTSLSLRYPPRFSQVSTEEEALRQLESVSFDLVICMPGTGDNDSFDI GRHIKEKYEQIPIVILTPFSHGITKRIANEDLSAFDYVFCWLGNTDLLVS IIKLIEDKMNLEHDVKEVGVQLILLVEDSIRFYSSVLPNLYKFVLKQSQE FSTEALNAHQRTLRMRGRPKIVLARTYEEAMDIYNKYTNNILGVITDVRF PRVDKGEKDGMAGIKLCAEVRKKDPFVPLIIQSSETENAAYAAKYGATFI DKNSKKMDVDLRRIVSDNFGFGDFVFRNPETGVEIARVRNLKELQNILFA VPAESFLYHISRNHVSRWLYSRAMFPVAEFLRPITWHSLQDVDAHRKIIF EAIVKYRKMKNQGVVAVFKRDRFDRYSNFARIGDGSLGGKGRGLAFIDNM VKRHPEFEEFENARVAIPKTVVLCTDVFDEFMDTNNLYQVALSDADDDTI LRYFLKAKLPDRLVEDFFTFFDVVKSPIAIRSSSLLEDSHYQPFAGIYNT YMIPYLDDKYEMLRMLSDAIKGVYASVYFRDSKAYMQATSNVIDQEKMAV ILQQVVGNQYGDRYYPSMSGVARSLNYYPIGDEKAEEGTVNLALGLGKYI VDGGMTLRFSPAHPSKVLQTSELDIALKETQTRFYALDLKNAGDNFSIDD GFNLLKLHVKEAEKDGSLRYIASTYDPYDQVIRDGLYPGGRKVITFANIL QHDVFPLARILRWVLRYGQQEMRRPVEIEFAVTLNHDRDKTGTFYLLQVR PIVDSKDMLDEDLTTIPDEDVLLRSNNSLGHGIMNEIHDIVYVKTDHYSA SNNQNIAWEIEKINQQFLNEGKNYVLVGPGRWGSSDTWLGIPVKWPHISA ARVIVEAGLTNYRVDPSQGTHFFQNLTSFGVGYFTINAFMNDGVYNQEFL NTQPAVFETEYLRHVRFERPIVVKMDGKKKLGVVLMPDK >BF1275 putative cNMP and DNA binding protein, possible regulator MENGIKKILRDKYGLFEKDIEILLEKFTKFSVPKREIILQERQTDHYIYF VEKGIVKSTILREGREFIIFFALENDVPLSSPNLTESRQSLYTLEAVDTC ILWRISRKDLATSFKDSLNLSNWGRMILQEWLTSSSFYFSSIHWMSKKEQ YQYLLKEMPKLIQRLSMRDLSAWLDITPQSLSRIRADMH >BF2495 conserved hypothetical protein MEEKLVTLAILTYTKAQILKNVLENEGIETYIHNVNQIQPVVSSGVRLRI KESDLPRALKITESSAWLAESIVGEKTPKVEHRTKKVLIPVDFSNYSMKA CEFGFNFAKSFDAEVILLHVYFTPIYASSLPYGDVFNYQISDEETVKNVL HKVHDDLNTLSEKIKQKVASGEFPDVKYTCVLREGIPEEEILRYNKEHRP RIIIMGTRGKNQKDIDLIGSVTAEIIERSHTTVLAIPENTPFNRFNEVKR IAFMTNFDQRDLIAFDSFINGLSPFHFSVSLIHLSDVKDTWNEIKLAGIK DYFQKQYPDLEIHYDVVMSNDFLNSLDNYIKTNQIDIITLTSYKRNIFSR LFNPGIARKMIFHSDTPLLVING >BF1281 putative two-component sensor histidine kinase MEFINPKFKYIFASILLLGGFLCGYNFKQWYVTNHRNEKHISLIYSCSKK EADRGQFEELLKKEFRSKGVEPIFDKYYLDCNRFGQAVEMEHIGNYLGVL KSKPIDLIMVMGDQATHSLLSTRHPLLYSVPVVACNVHFPDENLLKKYES RKVYALRDTPDFKHNMEFIRSLQPHVGLEIVYNIDLTPLGHKSFDLLNQV VDRKDVQILGHKSAFSMEYEYKEMREMIEFYNLMPAVANNRIKKNELTIS LCPFRYIKGASLLVMMENSKSEQGKKAFLLDKFDMVSFPIVNALSIPSFS CVHAGFGEGNKIVGGYMATKEISVQAAADLSTRLMNKEKIGMPKIRDLRK EYVLDWSVFSTYNGYDIKNVGKNVRIINYPIYDHYREEFYLLGVLFVFAF IFISVSLLHTRRRSLIERKNLKILEEAHKRLTLSADGGQISLWNMQGSDI EFDDNYARLTGVEKRKFKRTDFLEYVHPDDSQLLSSFYEALCKSPGVEIQ RVRFRFDEKKGYQWYELRCRSLKDIKGEMMLAGIMQNIQESVEREHQLIV AKQMAEKAELKQSFLNNMSHEIRTPLNAIVGFTNVLLGEGSEEIDPDEKA SMLEIINHNNELLLKLINDVLEISRLDSGSLDFDMKEWNMTDIVKEIYKT YQPLIRPSLQFRLELDDTVPVPVHTDRLRFAQVISNFLNNANKFTQNGYI ALGCKVDKKHREVRIYVEDSGKGIDEKELMMIFERFYKTDEFEQGSGLGL AISKVIIERLSGCIKVHSEKGKGSCFAVILSLADAPENHMLN >BF2849 conserved hypothetical PhoH-like protein MGTKKNFVLDTNVILHDYNCLKNFQENDIYLPIVVLEELDKFKKGNEQIN YNAREFVRELDLITDDSLFTHGAPLGEGLGKLFIVTGDSEAPKVHESFPA RKPDHQILAVAEYLARKYPKMKNILVTKDVNLRMKARSIGILCEDYITDK VVNVDIFEKSNEVFENIEPDLIDRIYSSREGLDISEFDFKDIIRPNECFI LKSDRSSVLARYNPFTHTVCRVNKTKNYGIEPRNAEQSFAFEILNDPDIK LVALTGKAGTGKTLLALAAALGKLTEYKQILLARPIVALSNKDLGFLPGD ATEKVAPYMQPLFDNLNVIKRQFASNSTEVKRLEDMQKSEQLVIEALAFI RGRSLSETYCIIDEAQNLTPHEIKTIITRAGEGTKMVFTGDIQQIDQPYL DSQSNGLVYMIDRMKDQNLFAHVNLVKGERSELSELASNLM >BF3301 putative two-component system sensor kinase/response regulator fusion protein MKYIYRTYLSLLYFLCLLFCLPLEVHAYSLRQFSNRAGLSNSAILSLHQD DRGIIWIGSCDGMNIFDGTDIHLYTPINSSKTLLSGNLINQIIESEKDIL WVQTNYGLNRLDTKQQTSQSFTEFKGQYFMANNKDDMLFILKDDGYLYYY QREAQSFNRLEIPNLEFSHVLSMTVDSNNILWIFTSNEETQSYRIENTKQ GLILTRKNLFTHSCKLYHAFAEKDMAYFIDETYALYEYDFNNRQAYYIAD LRGQIEVHGEVSSIIKQKNDYYIGFKNSGLIVLKYMSSQKMKYQIQKTEI HSGIFCLMKDKFQDIVWIGTDGQGVYMYYNDTFSITNTLLDTPVYQISNP VRALYYDQEQTLWIGTKGSGILRIKKYTPDNSMPMSSDRITPYNSALADN SVYCFAPGCKDKLWIGTENGINYYSYLSRQLKELPIIANGEKVKYVHSIK QPNDTTLWVSTVGEGIVKVIFDASTATPTVKSASRTVIDNGRMASNYFFT SYQENDSILWFGNRGCGAYRMNVETGEMIPHRFDSIVSSQTANDIFAIYK NAKGYWLGTSSGLLYLEQDDSLYTKADLFLNNTVHGVLEDHQGDLWLSTN QGLIRFNPETRTGQTYNSGNGLEITEFSDGAFYKDVVSETLFFGGTNGFI SIQTNDCITEEYMPQITLKGLSIFGKEHNIHKFLYEKEGKTILQLDYSQN FFQLNFMAIDYINGNNYSFYYKLEEMSNQWIENGTSTSAIFSNLAPGEYS LLVKYKNNINGQESQTQSVIIRITPPWYLSPLAYMVYFILFALLCTAGIY RLIYIYRRKQHRMLDKMNREKKEEIYESKLRFFTNITHEFCTPLTLIYGP CEKILANPEIDAYTQKYAKMIQQNTEKLNNLILELLEFRRLETGNKVLSI QQLSVSEKVRSIAESFEELAENKEMNYQLHISPGIEWNTDISCFNKIVSN LISNAFKYTPDKGIITIELKVENQSLIFCISNSGKGIAKENLSKIFDRYK ILDSVEMNGKNSRTGLGLAICKSMITQLNGEISVNSVLYEMTTFTVTLPN LPITERETTQTTYETGLLHTATEEPIVLEKTAIEFDTGKRTIMVIDDDNS MLWFVSELFADKYNVRSFDNAKDALSSLEQKQPDLIISDVMMPGIDGLSF AQKIKQHKLWSHIPLILLSALHHEDDQVKGIESGAEAYVTKPFNVKYLEK IVYRLIKREADLKEYYSSIFSSFTMEHGNCIHKEDQEFLDKMLEIIEKNI ANPDLQMELLSSEMGYSTRQFYRKLKPITEQSPADIIKEYRLTMAERLLI AKNLTIEEIMDQTGFNNRGTFYKLFSKRYGMPPRQYREQQKENVKKEKIS DE >BF1874 putative GAF-domain signal transduction protein MAEELTFISGSKEEQYLSLLPQVRSLIEGEVDLVANLANVAAALKEAFDF FWVGFYLVKQDQLVLGPFQGPVACTRIRKGKGVCGTAWQEGATLLVPDVE VFPGHIACSSLSRSEIVVPLIKDGEVWGVLDIDSDLLNFFDETDRKYLEE MCGYLSK >BF2844 putative regulatory protein MAVKILSVDDELDLEVLLTQYFRRQIRKGEYEFAFAHNGLEALQKLLETP DFDIILSDINMPEMDGLTLLAKVNELKNPAMKCIMVSAYGDMDNIRSAMN KGAFDFATKPIDLDDLSRTIEKAIEQVRYIRESQQEHNQLESIKNDLAIA GEIQQTILPRSFPPFPELTEVVDIYASMTPAKDVGGDFYDFFQIDDERIG LVIADVSGKGVPASLFMAVSRTLLRATALRGVSSAECLTYANKLLCKESL DSMFVTVFYGIYHYKTGMMDYTNAGHNPPYLLRGGRTVECLPVASNFVVG VFDDIEFESNTLTFGIGDTLLLYTDGVTEAFNDKREQFSESNLQDILASM HESSSAKEVVTSVLQSVKTFSGDYPQSDDITLLSLQRIK >BF3364 putative two-component system, sensor kinase MAKKHRKESLDALFREKVLLEMLKIAGVGMWTYSTETGRLRYIGFADTIH RHDELQYVDPADYLKLMNGEDLQTVTQFMADIHAGRPPQEGIRYKIHGNG EDFYLENHVVTCQPLGNGFYYLKGYVKNITAQVMEANRLCIEKERTEQAD RLRSAFFAHVSRELRGPLNRIEELASQMVHAESVEEREECFHRIQENRRM AMKIADALHAVSQLPVSTYEPYHSPMQLCLIYRDLLMENGYSHNPEDGEQ EENANFLSLLFS >BF4270 putative anti-sigma factor MIAGESSSEEMEELAHWNVVETKMKKQFDAAKNIVENGAIERRIWDKIDS RCQAPVERSQKLQLRYWRVALAACITALLIIGGGIFFFDKGHTASQRIIE YTEVVSSNSRLYVLPDSSKVWMQAGSRLRFSQDFMSNREVWLEGVSTFEV TKRKGHNFKVYIDQAFVEVKGTVFRVQSTCQDGAEVTLFSGKVDFNVKAS QRKVEMKPLQQIVFHPEKDEVILKNIGNISWDEGRYKFVDMRMDDLIEAI HDIYHIPVELDRKVARNDLFTGYMRYDDPASKVIEKICINMNLKFKKETQ KIIIYK >BF3174 putative two-component system sensor kinase/response regulator fusion protein MNRILFLLGLMLSGLLVSCSPDAPRYTIGVSQCSDDTWRHKMNDEIQREA LFYGGVKVETRTAHDDSRRQIEDIRYFIRQKVDLLIVAANEGMALTPVVE EAFDKGIPVIMVDRRILSDKYTAYIGADNYELGKAVGNYIAHRLKGRGKV VELSGLVGSTPAIERHQGFMSAISQYPDMTLLASEDAGWLQQPAEAKMDS LLQRFPEIDAVYGMNDRMAAGAFRAAGRRGREKEMIFVGIDALPGKGNGV ELVLDSVLDATFIYPTEGDKVVQLAMDILEKKPFERETKLKTAVVDAVNA HVMELQTNHIGELDGKIETLNDRVGIYLSRVATQRIVLYGGLIILLLIVG LLIVVYKSLRSKNRLNRELSRQKEQLEEQRDQLIELSHQLEEATHAKLVF FTNISHDFRTPLTLVADPVEQLLADPSLEGDRRRMLLLVQRNVQILLRLV NQILDFRRYETGKMEFTPVPLDLLQCFVEWNDSFQAAARRKHIHFSFDSM PDTDYHTQADAEKLERIYFNLLANAFKFTPENGKVTVRLAALQKDGAPFF RFTVANTGSLISAEHIRSIFDRFYKIDRHHTGSGIGLALVKAFVEIHGGS ISVESDERLGTVFTVDLPVRTCEEGACVVTAPMEESAPDRVDSLLCEDEA ENLNDPSKPSVLVIDDNADIRAYVHTLLNSEYSIIEAADGTEGIRKAMKY VPDVIISDVMMPGIDGIECCRRLKGELQTCHIPVILLTACSLDEQRIQGY AGGADSYISKPFSSQLLLTRIRNLIESRQRMKQFFGDRQTLAKEDICDMD KDFVERFKSLIEVKMGDSELNVEDLGKEMGLSRVQLYRKIKSLTNYAPNE LLRMARLKKAASLLASSDMTIAEVGYEVGFTSPSYFAKCYKEQFGESPTE FLKRSGL >BF3054 putative two-component system sensor histidine kinase MKRLILIIIVCCRALGWCHANTQTETDSLYRVAQSLPHDSTRLEMFKRLA QIEQLTPRCITFSGLLREEATLQKNDRYNTIAAYLHTVYYYNQNNRDSVK KWLDTMEPYARKSQTWDLYFDALRFQIDLCTYEEQYELAINEANLMYERA QKVNCARGLIGAKQCLGNVYISTERWDEGMKALEAAYQLSLQTDNAVVRI SILCQLISITKDQKNNQLLSEYLAKLKETLHHHTSTNPMLKEAFYDVYLF CEVYYTYYYLYAGQPEQAHKNLVKAGKFLNGNTFFLYRVLYYDAYAAYFR ACKAYDRALAKIDSTIMLLQEDFNSNYIHQKLTKADLLAEAGRSAEAIPL YIETLHLKDSIETTVLDKQMQQIKAKYNIDKVALEEERLKSYIQLGTLIV VVIILIILVAFMLRISHVRKALERSEKETRETTRMAEEANEMKNRFLSNI SYHIRIPLNGVVGFSQLIASEPNMPDELRKEYSSIIQKNSEELMRLVNDV LDLSRLEAGMMKFNIQEYGLAELCNEATYMARMHSEGCTVIRLENEIDTD LNIRVDTVRFTQALLSALTYPQKYKEKREIDFKVTLDTEKNFINFRITNS PLADERFTSQEVCIRHEINRLLFEYFGGNYKVQTNPDGKPTILFTFPSGR N >BF0401 putative transmembrane protein MKFIYSILFALLWIGVTITFGSYLYRMGLPIVNASAQKLLLRTIDEDLEC RFRKLKPNQAYVTGKKHTKNKKVTLTDKSGTHNVRQFAIDTVYTDTSFVH RVKQSYLIERNSINVDSLNQKWQLKLRMDGICANTGIKLTNSLKNGERIS ASSGLNEPDCFLLAYSTGVGYGIKMDAFIRPFWATVVLKAHWNNIWTWNY VLFSLIFCLFYVPGVRLFLVQVLSKFRIVDNHVKSSQPLAQQKGEFVWEV DGLTFDYLQRSITYHDQTCILRKQVAEVLLAFLKAPGHLLLNEDLKKLFW KELDNVDSFMERRNRLITDLRTDLRKIGANLSVTLVNGGYQLHFSLENSK KSVKNQ >BF0970 putative anti-sigma factor MDESCYINESVLLNYFAGELPADRRKEVEEWIAASEDNEKMARDIFRLYR AADTLDYMNRVDASAALQQVKGRIHKHRHRISWMVWGQRIAACMALPLLA TTLYLILKNPPQEYVEIRTNPGMVAEANLPDGTKVWLNSGSSLKHPVKFT GDTRTVELDGEAYFSVRKDRSKRFVVNTPFNIQTEVLGTEFNMEAYRTDS VVRTTLVSGSVRLSFLGKGDTKETFVMKPDEEFVYNTATHEARAEKSYVE IYTAWKNGQVVLKNTSLAETLKILSKRFNVEFIVKDSTLYANSFTGVFSR QYLPLILEHFRYASGIQYKYLDLEYDATHKAIQEKTKIELY >BF1413 putative anti-sigma factor MDKDLLYNFYKGKVSIEEGQRVKAWVEASDENERAFYRERKIFDALMLNN PLPVKKTSFFNFTHYKKIEWLKIAMTVILTFLLSYFYQEYKAGLDSVAMS TISVPEGQRTNVTLPDGSNVWLNACTTIQYPTSFNSRERFVILKGEAYFD VKKNKSRPFIVHTDAYSIEVLGTKFNVDAYPETEKFETTLMHGSVKVTLK ADSSQTVILKPDHKLSLEKGRFVMTKVEDYNPYRWKEGLICFSDESFPNI MKDFEKYYGVKIVIENKNVLQINFTGKFRQTDGIDYALRILQKNIDFQYE KDNEKQIIYIK >BF3901 putative LuxR-family regulatory protein MEAKAEILLVDDHALVLEGMRRMLESVPDVRVADAVTSGAKAAELIGERD YDIYVLDVNLPDISGFDLVDMIREINESARIIISTMHEEIWIINRLIRQK VNAVILKSSEAVEFENAVKSVLEGNPYTCPRFQSIRQKLSLSPVQIHSKD IPTKRELDVLKAVARGCNTHEVAAELKISENTVETFRKRLIQKFCAKNAI DMVVKAMSKGWIELE >BF4102 putative two-component sensor histidine kinase transcriptional regulator MQSRCDALANQVNPHFFFNSLNGISSLIRKKNDENTLTYVNQLSDIFRYI LQSDRKGVVTLREELEFIQSFRYVMEVRFANKLSFTIDVDEAQKDVLTLP VLSLLPLVDNVTVHNRIDSEHKMDISIRLNEQYELVVSNPIYPKLSPPDT NGTGLSNLENRFNLLMNKQIRIETDEKVFRVYLPLI >BF3929 putative two-component response regulator transcriptional regulatory protein MRSILIVEDDITFGMMLKTWLGKKGFNVSSVSNIARAQKHIDAQPVDLIL SDLRLPDHDGIHLLKWMGEKELHIPLIIMTGYADIQSAVQAMKLGAQDYI AKPVNPEELLKKMSEALQKKEAPLPKTPLTEKSPKTKQESHSYLEGESDA AKQLYNYVSLVAPTNMSVLINGASGTGKEYVAHRIHQLSKRSDKPFIAID CGSIPKELAASEFFGHIKGSFTGALSDKTGAFVAANGGTIFLDEIGNLSY EIQIQLLRALQERKIRPVGSNSEITVDIRLVSATNENLEQAIEKGTFRED LYHRINEFTLRMPTLKERGGDILLFANFFLDQANKELDKQLIGFDANASK ALLEYHWPGNLRQMKNIIKRATLLAQGSFIGLAELGSEILETQLSTPKMT LRDEDAEKEHILEALRQTGNNKSRAAQLLDIDRKTLYNKLKLYGIDL >BF1451 putative two component sensor histidine kinase protein MSVKGFFFILVFFLVAIMGFLIYISETVVVKYLYIAEALMLLLMLYLILF YRKIVKPMNTIGSGMELLREQDFSSRLSHVGQQEADRVVNVFNRMMEQLK NERLRLREQNHFLDLMINASPMGVIIMTLDEEVSQLNPMAMKMMGVRPEE AEGRKLSEIDSPLALELAAIPNGETSTVRLNDSSIYKCTHSSFVDRGFQH PFYLMEGLTDEVMKAEKKAYEKVIRMIAHEVNNTTAGITSTLDTVEQALS ESEGMEDICDVMRVCTERCFSMSHFITRFADVVKIPEPRFTPTNLNDLAF TCKRFMEGMCNDRNIRLQLICDESLDDVKLDASLFEQVLVNIIKNAAESI GQDGQIIIRTSLPTAIEVVDNGPGISKETEAKLFSPFFSTKPNGQGIGLI FIREVLSRHGCTFSLRTYADGLTRFRILFP >BF0916 putative FNR-like protein METMFDTLLQLPLFQGLCHEDFTNILEKVKLHFTRHKPGEPLIKSGEVCD QLLFLLKGRLSSVTVSEDDTLTVIEYFEAPAVLEPYSMFGMNTRYISSYI PHNEEAQMVSISKSFVMGELFKYDIFRLNYMNIVSNRAQNLYTRLWDKAP KDIEDKIIRFILGHIERMTGEKLFKVKMDDLARMLDDTRLNVSKALNGLQ ELNLLELHRKEIRIPDLSLLTEWNEKR >BF0998 putative sigma-54 dependent transcriptional regulator MTKAEIQQVKLRFGIIGNTEALTRAIDVAIQVAPTDLSVLITGESGVGKE SFPQIIHQYSRRKHGQYIAVNCGAIPEGTIDSELFGHEKGAFTGAIGERK GYFGEADGGTIFLDEVGELPLPTQARLLRVLESGEFIKVGSSKVQKTDVR IVAATNVNLTQAIAEGRFREDLYYRLNTVPIQIPPLRERGEDVLLLFRKF ASDFAEKYRMPAIQLTEDAKRVLLSYSWPGNVRQLKNITEQISIIETNRE INAPILQSYLPAQSTQRLPALFGVKTGKSFESEREILYQVLFDMRQDVTE LKKLVHEIMSERGAVTSNVGTFYTPAPVVAPTPSVPAIIHPVKPNCPDDD DIQDTEEYVEESLSLDEVEKEMIRKALEKHHGKRKSAAKDLNISERTLYR KIKEYGLE >BF3767 conserved hypothetical membrane protein MTPELAYFLKINIAIALFYAFYRLFFYRDTFFQWRRTALLCFLVISPLYP VLNIQEWIRSHEPMVAMVDLYATIVLPEIEITPEVRAADWQSIILSTVNI IYWSGVTLLLVRFFAQLASILRLRLRCRKDQIEGIPVYLLDKESGPFSFF HWIFIYPQAHPQNELSEILTHEGTHARQRHSIDVIISELMCIACWFNPFM WLMKREVRNNLEYMADNRVLEAGHDSKSYQYHLLGLAHQKSAITLSNSFN VLPLKNRITMMNKKRTKEIGRTKYLLFIPLALALMIVSNIEAVARTTKSI AQEVMQTVEEQMEPENTVAVKESTSSPQAANHISQPQESGIAEQPAQEES REQIVFEVVEKMPEFPGGVRNMNHFINSHLRYPVIAQENGTQGQVIAQFV IQADGTLSDLKIVKSVDPLLDAEAMRVIKEMPKWQPGKQRGIAVATRVTV PIRFRLMDSDSAPSTDSNKNQENTIFDVVEQAPEFPGGMEACLKYMYKNI KYPAVAMEAGIQGQVVIQIVIDKDGKIHDPKIVRGVSPELNAEAVRVISN MPQWIPGKQKGKNVATRFTLPVRFRLA >BF4113 putative AraC-family transcriptional regulator MKERILNIETVHQCNCCLGCKTLHPLVSVIDLSKSNLEQQIIKFDFYTIL MMEGEIDDVLYGRKYYDYSNASLVFLTPGESIKINKSKALPSKGWLLAFH PDLISQTSLGEHIKDYSFFFYNPEEALHLSQREKAKAAECICNIEEELRH AIDCHSQILISRYIELLLDHCNRFYERQFITRCEANKKIMKKTDVLLKDY ILSGKLKYNTSPSLGYCAKILQLSSHYFNDLLKFESGKNIDEYFESKRLE MAKSMLLDSNNTVSVVTEKLGYPNIRYFSRLFKRITGVAPNNYRLSQN >BF0336 putative two-component sensor histidine kinase MNRHKLALSLIGIFIVQLSYAGYFKHIGREEGLSQSSVMAIYQDKLGRMW FGTREGVNIYNSNKMAVYKAWIQNGNRPDQKILIGNEVSAITGSQNGDVF LIVDHALLKYDIRKETFERLRQGSVYALTSHAGEIWCAGHDSIFRYNPQN NQLDFQLKTGISSINYLTINGNRFYIGAKEGLYTTENKGRVQCLIPKVDV YRIFQSSCQELWVGCRTQGLYRINRNGRINRIPYDPSSPNGISSEQIREF VEDQQGNIWFGTFDGLQKYDPSTQTYSLIKQEQRPGGLSHSSIFSLYQDV QGTIWIGSYYGGVNYFNPDNNAFNYYTYNPDRSDCLNYPFAGAMTEDKDH HLWICTDGGGLACLDRQAGHFTTYTAGGPNSLPHNNLKSICYDPKRDCLY IGTHMGGLSRFDRKTGRFYNYLNHSTKGLKEPNDVIFQVSFYNDQLIVSA RNGVFSMNPDTNEFRLLYDGYYYQTFTIDPKGFLWLSAGTNLYSINLKHP EEVKSFSLPASIGQFGISKILKGNNQYLYIATLGSGLFCYNEQTQTCINY TPEQNQLLSNYCYNLLQTSTDNILITSDRGITLFNPTTESFRSIELDNGL SLSSIINGCGVWMCSDHTIFIGGTGGLSSFLEKDLNKEYPKPKLYFSSLS VNNARISPDDKSRILTEGLPFVREINLNATQNNLTVEFASSNYVDILNNT WYEYQLEGFDKQWSLTSQTSLKYTNLDPGDYVLHVRQKGNSLKMRKAQEI LLQIHINTPWYLTWWAWLSYITISISVTYFIWREKSSRRTLAILRQSLSS LTYHQILFNPAI >BF3162 putative carbon starvation-related membrane protein MITFTICLLALIAGYFIYGRLVERVFGPDDRKTPALTHADGVDYIPLPTW KIFMIQFLNIAGLGPIFGAIMGAKFGTASYLWIVLGSIFAGATHDYFAGM LSLRNGGESLPEIVGRFLGMTTKQVMRGFTVVLMILVGAVFVAGPAGLLA KLTPDSLDTTFWIIVVFIYYILATLLPVDKIIGKIYPLFAAALLFMAVGI LVMLYVHHPVIPELWDGLQNTNPEAAVLPIFPIMFVSIACGAISGFHATQ SPLMARCMTSERHGRPVFYGAMITEGIVALIWAAAATYFYREHGMEENNA SVIVDAITKDWLGAVGGVLAILGVIAAPITSGDTAFRSARLIVADFLKLE QKSMRRRLYICVPMFIVAIGLLLYSLRDKDGFDMIWRYFAWANQTLSVFT LWAITVYLARARKWYGLTLVPALFMTAVCSTYICIAPEGLGLSHWVSYVT GGLCTLIGAVWFIVWKKGIGYSYKK >BF2250 putative exported protein MKKLIFFLLLLLSTASLSAQSEQPSDSIRHLPSTVKQYGDFLIDMGLFIA APPKLPKYKFELPDASKDYNRIFSLNPDVIMTQGLSNVFTPSLSYGFGWG GHDFFSSPQQLQMGSFKLKNGMRLNTYGEYNADGKKVPNPAAMPWEKNNF KGAFEMKSSDGNFGIRIEVQQGRNYPY >BF2449 putative two component system histidine kinase MKRYSISVVLHILLLVVLSIGGYLLFCYELWFSTLIVGILLIATGVHLYS IQMKLAGMMRRLTDCIRFNDMTQNFQPPFKSKMMVELADELSQTLRLFRG RLLEEEIKHQYYENLLNKVDTAVVVTDRSGRVEWMNRAAVALVGQESRLP QEWLTTSWNETQVVRIRQQGASVEMAVSCTLFAAQNKERLLVSLKNIHSV LERNEMEAWQKLIRVLTHEIMNSITPIISLSETLSERGIPERLSEKEYGV MLQAMQTIHRRSKGLLGFVENYRRLTRIPTPARTLVAVDELFSDLRKLFP DSFIHFAATHRGATLYIDRAQIEQVLINLIKNAKESCGQNTAPQIEVELE QVPGKVCSLTVRDNGEGILPEVIDKVFVPFFTTKPSGSGIGLSLCKQIMN LHGGTITVSSEIGKGSCFTLMFPGR >BF0313 putative cAMP-binding DNA-binding protein MKNIINKIRQLYPVSDEALQALQANMQVKYYPKDTYIVQSGITDRLVYFI EEGVTRSVFHHNGQDTTTWFSQEGDVTFGMDSLYYKQPSIESIETLSDCK IYVLHIDELNALYEKYIDIANWGRILHQDVNKELSHMFVERLQLSPKERY EQFNRRYPGLINRVKLKYVAAFLGISIYTLSRVRAKK >BF1447 putative two-component system sensor histidine kinase MNKRLYTIFLISVFLLLPGFSTAAERIYNVLFVQSYAPETPWHNDLVRGL KDGFGESGLKVNITTEFLDANFWTYQSEKLIMRRFCERARERGTDLIVTV SDEAFHTLLTCGDSLALQLPVVFFNIKYPEGSLIDSLPNVCGYTANPDFG ELLRQASRLFPTRTEVVCISDNSLLSSKGKDDFMNEWEGFVEEHPEYTVT FYNSQTDTTNKIIASTCYPRNTHKTLIIAPKWSSFMSFIGRNSKAPFFSC ENLALTNGAFGAYDADSYASAHEVGRTAADVLRGKSPSEVGIIESPLKFM YDFKQLVFFKVDPKQASAIGGTIINEPYMEKYRMLYILLYSSILALLVFL IVWLYRINRRESRRRIHAQTRLLIQNRLVAQRDEFDNVFHSIRDGVITYD TDFRIHFTNRSLLKMLHLPKDEAARPYEGLPAGSIFKIYNNGKEILRPML KQVVTEESSVVIPENSFMQEVHSGSYFPVSGEVVPIRAHGKITGMALSAR NISDEEMQKRFFSMAVDESSIYPWQYNIRTGLFTFPAGFLTRFGFAENKT TISRGEMDRMIHPDDQESAYEIFNRALAGLSQSTRMSFRQLSGDGNYEWW EYRTSVLAGLTTDTPYSILGVCQSIQRYKTTEEELTAARDKALQADKLKS AFLANMSHEIRTPLNAIVGFSDLLSDTSGFTEEEVKLFIETINKNCGLLL ALINDILDLSRIESGTMDFQFAGHNLPLLMKNVYDSQRLNMPPGVQLVLK LPENSKKYLVTDNVRLQQVVNNLINNAVKFTTQGSITFGYTEEEPGYTSL FVEDTGKGISEDGLRHIFERFYKVDSFTQGAGLGLSICQTIVGRLNGTIT VTSEEGHGTRFTVRLPDICE >BF0870 putative anti-sigma factor MKQATTGNKDIIKKLLTDSLSPEEREKLNNYKFVNQAIYSQWEQASDMYT DVDKEERMLTNVMHQIKKGKTGRFRQSLHRYGWVASIALLLICGTLSLML LSRKAEPEVWYVLNSGRQSMDSVRLADGTLVMLNAGSRLTYPKEFSGNKR EVTLSGQAFFSVHPDKVHPFVVKTKNMDVTALGTAFEVFSFDGDESVETV LLNGKVKVEPKDHKEQIKGEYILQPNEKLTCQVNGDIRIDRVDANSYSAW RIGGRLSFKNETLAMILPRLEKWYGQKIDCPQKTADHYRFTFTLRNEPLD LILNIMSHSAPLNYKLISNDYYVLEELK >BF2255 putative sensor histidine kinase MMRYIILLVLCAWTGIALAIDYHAKDSLLLQLKQTTIAAERINIYRNLAD ICFETPDEKTYLLNMYREAQKAGDTSGMLNALNDLVCGETKEYRMDSAYH YMELIKAIREPQETAPVLAYLQMRFFDTLCSHNETEEAITKELQFIEEKK SDEASLYSKIAQAYITGGSLHYNDMIKEALPYLETAMNLSKQLPPEKQIL FVSIIVWKLSNTYSMLNKCDSAIRILDENLQTQQQYYKDHYQTQRPFYNM AIHELRFYTSLLTNAISEAPEKMDYYWQQIVKLNKKLTNPYDRYNYFLSM DNYYLNQKPQPHYEKALVANDSLIQIAQEIIPNNLPGLYDIQSQTYEAMG NFKEALAYLRIATQYKDSLTTENMQKQLGELQIKYEVNKLNNEKSQLEIK NKRILVICLSIILIIVIFVCLYLYHDLKKEKKMKFHLRNLKQKAEESEKM KTAFINSICHEIRTPLNSIVGFSDLIFNDEIDKETREGFSQEIQKSTILL TSLIDNMLEISSLDVSQEKLPCKEANLNSICIQEMTLLNRSHKPDIDYRI DLPEHPIILTTHEKYLSLVIEHLLNNANKFTEKGIITLHCHIDEARQQVH ISVTDTGCGIPADKHKEVFERFSKLNAFTPGNGLGLYLCQLIIRRLSGKI SIDPTYTGGIRITVILPVQ >BF0205 putative transmembrane protein MVMSWEKTIFGCLIGGYALLGLLGGNYAYEQEVKALHVYADSVFHEAFHV ELQKRGMDQVESWRYGCEDSFVSSVDTAFKKVTIQDEYGTYSFRVDAMKI RKNIVSSPGEQGLHTVVCLTHPLSVDTLNILWRTMLNERQKFPIRTGLKL TVSDNNGVVRSSFSPDSLSCLSYSSIFTYYVGYRCEIEILGFVSISFFSV FVNIVWTLIGVVVAFVLCVILTIYIYKLSVHPPKIKEVTTYIQTVAVKKG TLPIYDLKDDLKLDVGKGVLICENMEVSLTPQQRVLLVLFIKAENHTLSM SQIMADVWPGKSISPDCFHKAIERLRDLLRQLPMTIQIEYLGEEIYQMQI L >BF0967 putative two-component sensor histidine kinase MKQTPFRCLCLLLILLGAVHSRLSAHTDKTREDVLFLNSINFNLPWAKDV FWYTHQALQKKNISVKAESLSVPALCNRKEAAAVVEQLRRKYDVPPRLIV FIGDPGWIVCRELFDDVWKDVPVIITNTRDRLPATLDILLSHEELTESNT VPAYEWRKGYNVTTLGQVYYVKETIGLMRQLMPDMKRLAFISDDRYISEA VRGDVEQAMTGSFPELAFEQLSTRNISTEMLLDTLKSYDKTTGLIYYSWF ETHNQDDNNYLFDHIQEIITRFVHSPLFLLAPEDLSNNTFAGGYYVSVES FGDSLLQLIHRVLEGEFPRDIPPALGGKPAAYLCYPALQSYDIPVSLYPK EAVYINLPVSFFEQYKKEILMTVVLLLVVVSAVGYYIHILKRAHQRMKEA QLKAEEANQLKSAFLANMSHEIRTPLNAIVGFSNLLSMVEDKEEMLEYAG IIETNTELLLQLINDILDMSKIESGMYDFHVTQVDANQLMSEVEQVARLR IRTDEVSLSFAERLPQCVFHTDKNRLIQVLTNLVVNAIKFTSQGEIQIGY RLQDAHTLYFYVSDTGCGMSAEQCEHVFERFVKYNTFIQGTGLGLSICKM IIEKLGGEIGVQSESGKGSVFWFTLPYRASASL >BF2207 putative two-component system, response regulator MTKMGTIIIVDDNKGVLTAVQLLLKNHFSKVITLSSPVSLSTVLREENPE VVLLDMNFTSGINNGNEGLFWLHEIKRQYRDLPVVLFTAYADIDLAVRGI KEGASDFVVKPWDNQKLLETLLNAASQAKDGKKKNRKKESSPVSAMYWGE SSAMQQLHTLIEKVATTNANILITGENGTGKEMLAREIHALSPRSAESMI SVDMGAITESLFESELFGHVKGSFTDAHADRTGKFEAADRSSLFLDEIGN LPFHLQAKLLTAIQQRSIVRVGSNQSIPVDIRLICATNRNLQEMVDKGLF REDLLYRINTIHVEIPPLRKRKEDIVPLAERFIARFCKQYDKASISLSPA ACEKLTAHAWYGNIRELEHSIEKAVIISDGETIPAEMFQLVQKTENPETE TSTLEDMEKAMIRKALDKCGGNLSAVAAQLGITRQTLYNKMKKFGL >BF2843 putative anti-anti sigma factor MEKYEIHFVGSVLDSNTSGDEQAKIVALIEQGHSVALDLSGCSYVSSAGL RVMLYAFKLAKAKSRDVCLVGVSQEVKDVMHMTGFDKFFRFYQTLDELSQ P >BF2921 putative arsenate reductase MNLLIISNADSCRSRIAQALLSSFGKGMKVYSAGTMPAAEIHPLVLKLIK ETDIEPNTQPPHSIREYTNENWDHIIVLSGTADDIRNLFRKEVKHWYHLP FEDLFSTAAPSEAELWDRLIRLKEDIQRKMYELYRDDLREQLLPRCSCGA NDFCRCE >BF2723 putative two-component system histidne kinase/reponse regulator fusion protein MDIKDYILIINTYTESFPWSNRLISTATNFVKDDPKLAVYTEHMNMIMID NDSILDQFKDSLFDRYGSHRPRMLLLLGNSSLILKDDLRKMWGDIPMVLC AGKDYTGPEHYYLTKQPIPLSERVPLAELSQSCNLTYLYANLYIHENVEM MFRTLPRMKRFIYVGDERFVNQVNSQEIQEILRTKHPDVHYTFLSSRDIK KTNQLIDSLNFVDPRTTGILFSSWFHKRQFAGNMMLTMILPEIVSTVSPP IFALNMIELNDKESGMVGGYTYDQNHFNEKLSNMFSEILSGKSPRDLPHY LPTDGTPLINYQVLVRKGLSPDEWPAHTRFLNKPITFWDKYKYFLPGTTV CIALLVWFFLYRIRTLTHLRQIQLKEIEAMANYKNLIDNMPLLYMQEKLI VNEQGVADDLIYLNVNPHFEKHFFRREDVVGKRASELFPESLPEFLHFIQ ISLKENRAITFPYYFKKIDRFYDIVLKGAHQENVIDIFCVDSTELHRAQQ KLNATNHKLSMALEVADIIPWKWDLLSKTILCDINKPIELSAQGNNVSEE QLAVPDSQYFSKIYKEDRIRVEQAYKDLIEGRLEKVKEEYRVINIRNHTH KIEWVEAQAAVETRDENGIPVTLVGSSQVITGRKKMEMELTSAKDRAEES NRLKSAFLANMSHEIRTPLNAIVGFSGILASTEEEEEKQEYVSIIENNNA LLLQLISDILDLSKIEAGTLEFQYSDIELNTELKKLESTLKLKLKSDDVQ LEFVPGLPVCPVCTEKNRLSQLIINLVTNAIKFTSRGSIRFGYEHRGKEL YFYVTDTGCGIPKDKQESIFGRFVKLNSFAQGTGLGLSICRTLVEHMGGH IGVDSEEGKGSTFWFSLPYKAASTSAGTMQKTEIQPISVEKDKLTILIAE DNESNYRLFESILGHDYHLIHAWDGREAVERFKRENPQIILMDINMPVMD GYEATQEIRKYSAKVPIIAVTAFAYASDEQRVMENGFDGYMPKPINARQL KAQITEIMQKRIILL >BF4076 hypothetical protein; conserved hypothetical protein MSEYRFHLQKYRPGSKTTCPSCGKSRCFVRYIDEQGNICFPENVGKCDRE NSCGYHYTPKEYFKDNPDVLEMDEGNGKSLLSAPYKQADKTPSCIVPSYI PSSYVLRSLSHYSINPLYQYFCHVFGEDETTRLFEMYRIGTSSKWGGAAV FWQIDINGQVRTGKVMCYNAETGHRVKGPQAFVSWAHSELKLHDFRLKQC LFGEHLLKNSSSPVMLVESEKTAVVMSHFIPDYIWLATGGKNGCFNSEAM QVLKGREVTLIPDLGATEQWNAKSALLSGICKKVTVSDILERTATEEQRS QGLDIADFFLFSPSKRQILQLMIQRNPALQLLIDGLDLALVE >BF3582 putative regulatory protein (possible anti-sigma factor) MSFYEKKKMEKNHYIHYTAADLLNDGTFLDSMQHPTEQSEKFWSQLEKEN ETFAGELRMARSFLMAVAESPQKRMTDDEVGTLWERISRQVAMEKRVKRK KQLLFLRVAGIAACISVLALSSYFVFSLISFYEESSCYSLAGISEPDSSN DIQLILSEGRKLVMDGKESRLHYKEGGKIAISSGKTQLDEENETGYNQLI VPSGKRSFITFSDGTRVAVNANTRVVYPSEFSGHKREIYVNGEVYLQVSP DKKHPFVVKTNRMEVEVLGTEFNVSAYDFTKNQSVVLVSGKVEVDTYKYP KKVLKPNDMLTYDGQDDGLRVNTVDVSEYISWVDGYYCFNHEKIEIITEK LSRYYGKRVIPDSGLIGLTCSGKLDLRDDLRDVLEVLSKTIPAQIETRDN YFLLTK >BF0168 putative two-component response regulator transcriptional regulatory protein MYSILIIEDEQRVADLLRVGLEENGYNCLVAYDGAMGLRMFRANTFDLVI SDIVLPKMDGFELCKEIRAANPAIPILMLTALGSTDDKLDGFDAGADDYM VKPFDFRELYARIRVLLKRKLAVVTDVEEELNYADLSVNLLDKSVKRAGR DIKLSPKEYNLLVYMIENAEKVVSRMDIADKVWNTHFDTGTNFIDVYINY LRKKIDRDFDTKLIHTKTGMGFILTDKL >BF2242 putative two component system sensor histidine kinase MKIGRKIALFYTLVTVLTTMAVIGVFYLFSSRYIDGLYRSYLREKAFLTA QKHWERDEVDEQSYQTIQRKYDELLPEAKEILLDMDSDAVVRDTLNKYLS ASQQKQLLESKEMSSVSFVYQDMLGAALYYPDNEGNFIVIIMSHNSYGVK IQEHLLLLSAFLVLCSSVLIFFIGQLYSTRILIPLQHVLLQLKQIRGNSL NRRLKTTGNKDELDHLIETLNSMLDRIDTAFRAEKSFVSHASHELNNPIT AIQGECEISLLKERSTDEYIEALRRIAGESKRLSNLIRHLLFLSRQEEDI RKNNVEEIRLADLLEEAGAANPRIRLQYPEDAARYAVVSASPYLFKIALQ NVIDNACKYSQGEVLIRLYKEDERWGIAVKDSGIGIPADEMELIFQSFYR GSNTREYVGQGIGLSLSMKIFSVYRGKVSIRSEEGKGTEVRVVFA >BF1931 putative two-component system response regulator MKLRCAIVDDEPLALSLLESYVNKTPFLELAGKYSSAVQAMKELPGNQID LLFLDIQMPELNGLEFSKMVAPRTRIVFTTAFGQYAIDGYRVNALDYLLK PISYVDFLQAANKALQWFELVQKPEEVDSIFVKSDYKLVQVELKKILYIE GLKDYIKIYTEDAPKPILSLMSMKSMEELLPPARFMRVHRSFIVQKDKIR IIDRGRIVFDKTYIPVSDSYKQTFQTFLDERS >BF3925 putative two-component system sensor histidine kinase/response regulator fusion protein MAIPSRFTKVKIAAGYTLLLVVLLLSLLFVHREMEKLSDTDDVQSLQTDS LLLLLKEKDENTIRMLQIINEANESMITPVELDSIIAEQDTVITQQRVQH RIITKRDSVITKRKKKGFFRRLGEVFAPSKEDTAVLVNTAVEFATDTILE PYNPIDSLHQRIRTVTKRKSRPVVRPNYNARLRRMNKELTTRIDSMITTY EQVVTQRAMDNASEQQELRNRSTRTIGGIAIAAVLLSACFLIMIWRDITR SNRYRKELEEANKRAEALLEAREKLMLAITHDFKAPLGSIIGYTDLLTGL TTDERQRFYLDNMKSSSQHLLKLVSDLLDFHRLDLNKAEVNRVTFNPAQL FEEIRISFKPLTDAKHLTLSCSIDAELDGRFISDPLRIRQIVNNLLSNAV KFTAKGSIALNITYHSSSVRIEVVDTGKGMAPGDREKIFQEFTRLPGAQG EEGFGLGLSIVHKLVTLLEGSISVQSTLGEGSRFIVILPLYPVGPVTGEK REGNVSSVSTTDQAGEDGVMASPKLNRVLLIDDDRIQLALTAAMLEQQGI QAVCCQQPDELIEQLRTATFDVLLTDVQMPAINGFDLLKLLRASNIPQAR TIPVIAVTARSEMNEQDFQEHGFAGCLHKPFTVKELLTIISGEEMTGSSA ELTPDSLNFRALTAFSEDDPEAASTIIQTFIEETEKNRNRMESAIRATDV DGIAGMAHKLLPLFTLLGASEALPLLLWLEQRRGEAVSDEMIQKANEALR QVDIVMAEARRYAAGD >BF3641 putative transmembrane sensor/regulatory protein MKYTDRELDRLLEKLIASTRSPRGKFSAAASYQILEKRLPRPALRLFSLR TLSAVAAIALLCFIGWNTYCYLKPAALQTISTLADTRTIKLPDGTEVTLN HFSSLTYPEKFKGEHREVNLKGEAYFEVTKNRKHSFIVQTESVNVEVLGT HFNVESYPDDPEVKTTLLEGSVAVSNKSNSVRIVLKPNESAIYNKEKKSM TLEVSDRVAEEIAWRNGELIFTNLPLQEIARQLSNTFGVDISITDTALQN YRITARFSSEEGLDQILDLLHTVGNFNYSYNNKEITITTKLN >BF3098 putative anti-sigma factor MSDAYKIIHNFMAFIASPDLKNKVWTWLLDPSGKQRKEEALLQIWDEYRP EADAGTRHSLRKFQKRAGLSSARPAYLHRWAHIAAILLIPLISIITAYIY VEHHTQEVRFVECIVPKGEQKQITLPDGSIITLNSGSVFLYPTQFTGDTR SVYLSGEGHFAVAPNKKLPFVVATNHLDICVLGTQFNLQAYPFDRRTITT LESGSVAVRKKNQPNSFITLEPNQQLDYENRSGRFNKTDIDASVYSGWTK GEMNFISQSLREILRTLERSYAVSIQLSSDLMESNRINSDLYTIKFKRRD DIFHVLDIVTKTVGGITYKVEKDESISICPLK >BF1590 putative two-component response regulator MNDYRILVVDDEEDLCEILKFNLENEGYEVDTANSAEEALKMNISSYHLL LLDVMMGEISGFKMANLLKKDKKTAQVPIIFITAKDTENDTVTGFNLGAD DYISKPFSLREVIARVKAVLRRTATSDTEKAPEQLCYQSLVIDITKKKVS IDGEEVPLTKKEFEILFLLLQNKGRVFSREDILSRIWSDEVYVLDRTIDV NITRLRKKIGTYGKRIVTRLGYGYCFETE >BF2190 putative two component system histidine kinase/response regulator fusion protein MNMEINPSEYKILIVDDVMSNVLLLKVLLTNEKFNIVTASNGNQALDQVK KENPDLILLDVMMPDMSGFEVSQKLKADPEAAHIPIIFLTALNSTADIVK GFQVGGNDFISKPFNKEELIIRVSHQISLVAAKRIIEAKTEELKKTIIGR DKLYSVIAHDLRSPMGSIKMVLNMLILSLPKEKIGEDMYELLTMANQTTE DVFSLLDNLLKWTKSQIGKLKVVYQDIDMVEVVEGVGEIFAMVAGLKNIR LRIESPECQAVHADIDMIKTVIRNLISNAIKFSNEGSEVLIKVEESDGMS VVSVKDSGCGIDEESQKKLLHTDTHFSTFGTNNEEGSGLGLLLCQDFVVK NGGKLWFTSVKDEGSTFYFSIPLKK >BF3292 conserved hypothetical protein MEYLFEIFWVILYSQTVNMILEDLIIKEIGLSFNSYGRLMDVCDEVVLKK KEFLLHQGQVCSFIGFVETGVLRSYIEKEGDDYISDFYFEGSFTTSYRSF LTREISVGSIQALEDSVIYRLSKSDYDQLLQESNEWYKLGKYIADTLFIK KCRKETSLLMDNALGRYKLLLQTYPNIEQDVSQYHIASYLGIKPESLNRL KSLNIGQ >BF0821 conserved hypothetical transmembrane protein MMGLFFVYIVKSSVCLAGFYLFYRLLLSKETFHRFNRIALLTLLLLSLLL PLVQLTTIEQTEVHQTMLTIEQLLMMADMPVSEVTPAEAVTLSGIQILLM VYLSGVLFFACRHIYSLGRLLMLLRSGEKEKMENGMTLVIHQQKISPFSW MKYIVISKVDLEEDGREILIHEAAHVRNRHSVDLLIADICIFFQWFNPAS WLLKQELQNIHEYEADESVIREGVNARQYQLLLIKKAVGTRLYSMANSFN HSKLKKRITMMLKEKSNPWARLKYLYVLPLAAIAVTAFARPEISGKMDEI SAVKVNDFVQIVGTKVPEKKVEVLKDTVKKDAPKEEAFEVSRLETVPTHS KVTITDGMKRSGMDLFSVRNAGSQPQPLILVDGKEITGEQMQRDINPDMI ESISVLKDEASTAIYGDKAKHGVILITLKGKDVQNVLSLSASDPEDGVKV VGVVKDHLDKPLAGASVFISGTVSGTMSDAYGRFVLLAPKNAMLRISYTG MTTVEKAVAPEVNVTLNPAD >BF2754 putative two component system histidine kinase MKLIYRIIIRIALMLTVVLGAWAVFFYIAVIDEVNDEVDDSLEDYSETII IRALAGEELPSKNNGSNNQYYLRKVSKEYADEREDICYKDSMVYIVEKEE TEPARILTTLFKDDEGQYYELTVSTPTIEKDDLKDAMLGWIIFLYIVLLL TILIVCIWIFHRSMKPLYNLLRWLDAYRIGRPNRPLKNETQITEFRKLNE AAIRNAERSEHIFEQQKQFIGNASHEMQTPLAICRNRLEMLMEDDSLSEA QLEELIKTHQTLEHITKLNKSLLLLSKIDNGQFSDTRTVEFNSMLKRYIE DYKEVYGYREIELTLDEQGIFRAEMNESLAVALITNLLKNAFVHNVDGGH IRIEITGHSMTFRNSGAGRPLDATHIFERFYQGSKKEGSTGLGLAIADSI CKLQHLTLRYYFEKDEHCFELRKNNFTTDYAD >BF0954 putative FNR-family transcriptional regulator protein MVKMNLSEINVPERIAEMWAPLNAEQREFLANNFTLQNYKKNETIYCEGE SPTYLMCLLSGKVKIYKDGVGGRSQIIRMIKPTEYFGYRAYFAKEDYVTA ASAFEPSTICLIPMSAIMTLVSQNNDLGMFFIRQLSIDLGIADERTVNLT QKHIRGRLAESLLFLKESYGLEEDGSTLSIYLSREDLANLSNMTTSNAIR TLSNFATERLITIDGRKIKIIDEEKLKKISKIG >BF2206 putative two-component system, sensor kinase MKIHLKLLTERYWFRLGLSLCFAITAALSYADRDFIWMGLSLCLLLFSIW WQLSLYRIHTKRVLFMIDALENNDSAIHFPEEQIMPETREVNRALNRVGR ILYNVKSETVQQEKYYELIMDCVNTGVLVLNENGAVYQKNNEALRLLGLN VFTHIRQLNKVDIQLMKKIEFCRPGDKIQTIFNNERGTINLSIRVSGITV REEQLRILAFNDINSELDEKEIDSWIRLTRVLTHEIMNSVTPITSLSETL LSLADTRDEEIRRGLQTISTTGKGLLSFVESYRRFTRIPTPEPSLFYVKA FIDRMVELARHQNKCDNITFHIDIAPADLIVYADENLISQVVINLLKNAI QAIDTQADGKIEIQGRCNAAEEILIEIKNNGPAIPSDIADHIFIPFFTTK EGGSGIGLSISRQIMRLSGGSITLLQGKETKFILKFK >BF2281 putative two component system sensor histidine kinase MYLKEMNPRLLIPLFCMLLLTTFFSCVDTAPTKEVQHIDSLNSRAYMYRY RDLDSSCKAASQAYKEVSMYSQGKAEASNNLAFCAFMRMDFDTAERLHKG VYDLTKNELELLIADIGLMKIYQRTAMNKEFYDYRNSAIRRMKRIDEENN LFVDRHESARLDYAFTEFFIVSAVYYYYLQQRTEAMASLNEIQLNEDLAT DTNQILYFHYIKGSAGLCEGKTPDERKLEEFDELYTTWKMASEQGYLYFE GNGLQGLTNLMASQESYELFLNRRSHALTRFGIPVDSLLPLRLGQMALER FRKYNDLYQIAGAYVSIGKYLNAHGRYTEALDTLAKALDCVNQHHMSYYH SVADTLDKLQVFVPNKDVAYTEVTWLGKEKVKTVPEWISRIREQLSVSYA CLGMKPASDYNRNVYLDILRYTRQDKELESRYLSLEQESRQLNVVLFFVI IGLILVTAMFWLFNKRSKVRNRIHIARLRQTLDVCQKITASIPVDVTDES EIVYAISESIQPDMEQLFGATEIRIGIRNEETGDIEFNEECESEQTDEPK SIGEVGIGSVFNLYVPDKTESIGILKLFTRHRLNKDEQALVKVITPYIAW ALDNGMTFISLGDERNKLEKQRYVYEQHIAGNKRQNLIKKSCLAIVDGIN PYIDRIINEVHKLTEKGFINNDRIKKEKYQYIDELVTTINEYNDILALWI KMKQGSLSLNIENFELNELFELISKGRKAFEMKKQRLEIEPTKALVKADK ALTLFMINTLAENARKYTPEGGIVKIYAKRTDEYVEISVEDNGRGLSTED ITKIIGEKVYDSQSIGMKDNPDKEELKRSKGSGFGLMNCKGIIEKYKKTN DLFRICTFNIESTPGKGSRFYFRLPPGVRKIIGICLCLVGLFGFFSCQGE PMPEKLKDIPVDSVTLAAEAEYERLLDEASRFADTVYYCNVIENFELALQ YADSALNRLNAHYKKYARHPQRFMKLVGSGIPAELEWWVEPYNTDFHVIL DVRNEASVAFLGLKKLDAYTYNNVAYTALYKLTGEDQSLEGYCRQLERST TNKTVGIILCILLLVASLCGYYLLYVRKRLLNRLNLEQVLEINKKVFASS LVRTQESAEALQREEDTLKEIPQRIVNESFDSMNELLTIECLGIAVYNEM GHRLEFASTPRMDTPPEIIQQCFDNQTYLSDGDMQALPLLVDAGGKHQCV GVLYLERQEDSMQEADRLLFQLISRYVGIVVFNAVVRLATKYRDIEAAHE ETRRASWEDSMLHVQNMVLDNCLSTIKHETIYYPNKIKQIIGRLNTHSLS GEEEKECVETISELIEYYKGIFRILSSCASRQLEEVTFRRATIPVTDIMA YAGKYFKRISRGVDYKITLTIEPLEAKVIGDINQLRFLIENLIDEALSFH QDGELVLKAIMDGEYVRFLFTDKRREKQVEELNQLFYPNLARMTSGEKGE LRGTEYLICKQIIRDHDEFAGRRGCRINAEPAQGGGFTVYFTVPKR >BF1387 putative transmembrane AraC family transcriptional regulator MRKLLYVILLLLFRLLMFPGAVCAEILSLPDSLITDDNVYKYTFSDFDKA QQVMEQLRKRKSLSMFRMDVVEGDLYFNVGQYYKALKFYKRALDSDSVRN NDKNYMEQVHRMISCYDCLHNENKKSLYVYLLLKRAEQCGDKAMQSVALF NMGKMLYYQGNKEKGYEYLEQAIEMMSKTDYRYKYDNLRYDYNTLLIFQK SDRRNEEALRTLAALEKVVTEETGSETPMEGLSAKEKKAMYAHYAVVLFR LGQAEEAERYYRKFLAESEEYDRDDYLIMPYLFDRKMYDQVIRMNAAREK MYIMRGDTVNYYMTTIKRSLGWAYRDKGDYRTAARYFEQLAVLRDSIKNR EQKSAALELAAVYETNEKDLFIQQQAADMQKRNLLLVFTLCIVFLLGVLL WRTIRHNRIIRRKNKAMVGTIEDLLIHKEELYRKKEENLILKEQLEREQN LRMSAGGGSLSTDKDGKAETTVVPEPQAGDGNDIHDRILFDKLEHEIISR QLYLQPDFSREELIKTIYIPKNKFAPLFKQYAGMSFSKYINNLRLEYAAK MLKNHPDYTVDTIAQECGMSTQSLYRLFSGKFGVTPTDFQVGVQHINNKN ITEDK >BF2094 putative two-component sensor histidine kinase protein MKQKWARKPLILTAALLICCYTTVWLGMHGFYISLPVSVCLLLYTAYRIY RYILRSTRAMAQFIWSVRYSEFLSSPVQSEESLRSLPAELLNEMNQALDF YKQNLQKKESKLQYFQALANHIDMSVLVYTPSGRIEWMNEAAKRLLDNHN LKSIDELKYFHSELPARLYSLKAGDISVLQAKKEEETIQLALSGMEFVIQ GRPLTVASMKNIHSVLDSQETEAWQKLIRVLTHEIMNSITPVTSLSELLE HQIEDFDGNEEERAEIRRMLQTIRRRGDGLIRFVNSYREVSHLPQPLLKI YTSQELLTGVVRLMYREPNDLHLILPPKGQRLMADKDLIEQVLINLIKNA RENDATDIRISAGLSSGERPYIRIEDNGTGIEHEVLDRIFIPFFTTKPTG SGIGLTISRQIMHLHRGTITVSSEPGKGSIFTLLFPGVF >BF4313 putative two-component system sensor, no kinase domain MKWNVLLYGLLFSGLGIFSYLLLVNYTELTPKVADVLYSKGAFVFFITAF NVLGYSTLRISSWINTQYALNIRHRWKIIVIYVAVILLFLLLNYSLLIAA KLLAGIDNLFTFSNGGWRILIVVWLVELVIVGLLLANRSIQNNLKLQQEA AKLQTENDTARYAALQSQLNPHFLFNSLNTLIAEIEYNPGNAVHFTKHLS SVYRYVLQCQDKTLVTLTEELEFLQSYLFLHKVRLGDCISCNCCIASGYT SCMLPPLTLQLLAENVINHNSITLSKPMKIDIRLEEGYLVVSNPIQPKKS HESPGVGLKNLSNRCQLMLGKEIIVHNDEKVFIVKVPLLYE >BF4131 putative anti-sigma factor MEQELLYKYFKGTTSEEEERLILDWVDASPENRKAFQKERMLYDIALFTD EKQMNRKDRKARIIPMLRWSARIAAVVIVAISFGFLFKNYQYEKSACQQT ITVPAGQRAQITLADGTKVWLNSKSTLTYASNFGRKERNVELDGEAYFEV AKNKKIPFFVNTEINRVKVVGTHFNVCAYKGSNEFETTLIEGIVDIYPIG SDQVITRLTKDEFFGSYNGKYKKTTLPSYEYLRWKEGLYCFDDAPFNSLL NKLEKYYNVNISVRNLNILNYRCTGKFKEQDGIEHILKVIQKDHKFTYSI NEEKDSIIIE >BF3411 putative regulatory protein MKNYIQRIIRLFATSDPDPKLTGEIHRWLLDQEHAGEKETALHDLWNETE GKVDKTTWDSLASVYTKVGANSGDRHQPRIRFAHYAAAIALLIVSVSVTF QMTKQHFAEAPLIENITPDGRLSSLRLPDGSIVQTNSGSILLYPEKFKGE TRTVYLIGEANFKVKKNSGQPFIVRSGTMSVTALGTEFNVAAYPEENEMI ATLIHGKIKVECDNGKESYIVTPGQQVTYRKSTGESRLAEANIEDVTAWQ KGMYVFRGVTMSEILNELERRYAVTFQYNANLFNDDKFNFRFREKSTLED ILNIMQEVVGGFSHELKGNICYIKPETKK >BF0976 putative anti-sigma factor MNYEDIDHLLPRYCEGLATEEECRQVESWMEESEDNRKIVDQINTLYIAV DTVNVMRKVDTEKALKKVSSRMIVRKTTWWEWMQRVAAILFIPLSVAFLV QYMHNGKSAVCQMMEIKTNPGMTTSVVLPDSTVVYLNSESSLRYPSVFEG DIRNVELKGEAYFAVAKDLKKKFVVSAPHSSQIEVLGTHFNVEAYEDEPD VSTTLVEGQVCFHFSDKDYLAKKVVMKPGQRLVYSSTNGDVQLYATSCLS ETAWKDGKIIFNNTPLDVALRMLEKRFNVTFKLKNARLKTNAFTGTFTEQ RLERILEYFKISSKIQWRYLESPDIRDERSIIEVY >BF3076 putative membrane protein MGSHWGEKIRRYLQSLYPVAYQRWKVVLISSLVVFLILLVLQPFGISGIR QHKFWILVGFMGVTAVSLSIPMYVFGKLFPKFYKEETWTVWKQIVNLLQI LFFIAIGNWIYSTLVFGWGLRWDVFCAFALFTLVIGLFPTVLFILLNQNR LLAIHLKEATEMNLHLQRSVLPAESVETKQDSPFLLFQGGIRESLELDSK DLLYVESNGNYIRVNYQKAGKNVQCLLRATMKQAEEVTAVCPLVLKCHRA FLVNVRKVVKVNGNSQGHRLLLEGCPEEIPVSRGYSKQVKELIEGISGD >BF1589 putative two-component histidine kinase sensor protein MRLLLLCGESKLKNITYMNLPVTQKHFLSFSRKLFLSVISLFLVFAACFM AYQYQREKEYKVELLNIQLQDCNNLLYEKLYDHPQDMTEVISDYLQHNVL KDLRITVVNLDGKVLFDSQEQNVEQLGNHLDREEVQKALYNGVGFDVRRT SETTGVPYFYSATLYKDYIIRSALPYSVSLINNLKADPHYIWFTVIVTLL LMIIFYKFTNKLGTSISQLREFAMRADRNEPIEMAMQSAFPHNELGEISQ HIIQIYKRLHETKEALYIEREKLITHLQISHEGLGVFNKDKKEILVNNLF TQYSNLISDSNLETAEEVFNISELKEITDFINKAPKRPVGKEEKRMSITI NKNGKTFIVECIIFQDMSFEISINDVTQEEEQIRLKRQLTQNIAHELKTP VSSIQGYLETIVNNENLPKEKMNVFLERCYAQSNRLSRLLRDISVLTRMD EAANMIDMEKMDISVLVTNIVNEVSLELEEKHITVVNSLKKEIQIRGNYS LLYSIFRNLMDNAIAYAGNNIQIHINCFREDEKFYYFSFADTGVGVSPEH LNRLFERFYRVDKGRSRKLGGTGLGLAIVKNAVILHGGNISAKNNQGGGL EFVFTLAKER >BF1309 putative anti-sigma factor MVKTMDETKLLNYLKGESDAEECLEVEAWYHASAEHKKQLDQLYYMLFVG ERKVAMDGVDTENSLSVLKDRIKHKESEKKSVHRIHVSKWKRYAMPLAAF LCGLLVSVGALYWISSGKSAGYIFATESGQRAQAVLPDGTKVWLNASTQI VYKPSFWKRERQVDLSGEAYFEVSRNKTKPFVVNSNDVRTCVLGTKFNVR ARPSEEKVVTTLLKGSVKVQLPGQSEEEGILLKPGQMLSVDTRTMQPMLT EANRPGDVLLWINGKLKFEQATLQEIVQCLEKHFDVHFIISDAQLQKDRF TCTFSTDDDIRQILSILALTKRFDYKCEDNNIILTPKTNR >BF0949 conserved hypothetical protein, possible C-terminal metal binding site MKKESQVIFDKNVIEFVTVAAEFCAFLERAESMKRSTFVDTTLKILPLLY LKASMLPKCEMIGDESPETYVTEEIYEVLRINLASILAEKDDYLEVFLPD MAYSDEPIKKNISEDLADIYQDIKDFIFVFQLGLNETMNDSLAICQENFG LLWGQKLVNTMRALHDVKYSPKARGEDEEEEEYEPENNEDCHCEDDDCHC HDHGCHCHDDE >BF3005 putative membrane protein MNKRIFLVIGVIILFIMIAIGVSTYTIIHSLIQKEKEAFKPQVENILKEA VINNITQKTKDLALNGLSNSPNKIGTYETRTFCSKDTLFTYQHQVQDIDT EIFFARQLGLLMMDSLQSTDIQNLIINSLSKNKIKGYINVGIITSKHLQR EIWSQPQSSIPCNAEKIIYHLEDEIVSVDYIMYIDYSFSTLWKRMPKTNI YINLVVEVILIYTITLFVLYYRKQQKNRSVSTVDITSDPNIITDPISVDN TVETEKRTNSTIKEELSFKDQFVFEKDFVLFNDRPIKMPNQQQKILIFFL NRPNYRVNKHELKEEFWPKNSDPTNNMTSAINKLKKILEEINSKYTIITD KTNEEYYVLIRDKSAEKI >BF1344 putative transcriptional regulatory protein MREYIIADNQDITKAGMMFLLSKQKEVSLLLEADNKMELVQLLRIHPQAV VILDYTLFDFSGADELIILQERFKESDWLLFSDELSIGFLRQVLFSSNAF GVVLKDNSKEEIMSALQCASRKERFICNHVSNLLLSGSGNVNTASAVHTF VPQEDRLLTPTEKIILKEIASGKTTKEIAAEKHLSFHTINSHRKNIFRKL GVNNVHEATKYAMRAGIVDLAEYYI >BF1829 putative transmembrane protein MNSKYLSLPKTKKYIQKKYLQFKEIRNPKRQTIYFVYYGTVGCFSIGIIA DLCVYLIRKDLLLALCNILSLGLFLLFTYLLIRKKKQITFLLKCTFYTIQ SNILISMYCRIYLPPEETGFFLSQDLMIGMVTCGLASISVSRHTVMILSF APILLYMFIGVYTSSELYLMSLPSLAVAYIFPPIMLARLQEILRTMQRQK ARMTSELKLWAAFNALHLQPSSKEIQLCCLILENKTTEEIAALQYIATST VRSNRSRLRQKLQLNQETDLQTFLSELIKKDFDYLESPD >BF4326 putative two-component system sensor kinase/response regulator fusion protein MKNTNLFRLAFLLFAGLSIFLSSCQPKEEGDKKYVIGFSQCTSDSWREAV LLEMQIEASNYRNVELVVYNAMDNSSRQVSQIRKLISQNVDVLIISPNEA VPITDVAVEAYRKGIPTIIHDRKIQSDEYTVSIGANNYNIGSAIGEYING QLPPNSKILEIWGLEGSSPAMERHDGFIDHLRSDKNFQVTQVFGKWHYNS AYDAVNRLATFADIDLVYAHNDVMALAARDVIMKRDSVSGKRIRFIGIDG VYGDGAGLQAVADEKLEASFQYPTGGAISIQVAMQIINGEKVKKNYVLNT AIINRGNAKTILAQSEQLNHYQKRINRQKQEEDNLLSRFKFLRNSTILIL ALMLLIIPLLGYVMYMNLRVKNKNKELHDKNQLVEAQKEELAVKNSQIEN ISNQKLQFFTNISHEIRTPLTLILGPVNKLIKNSKLDPSIQEDVALMKRN VDRLYRIVNQILDFRRIDNDKMKLILRQVDLIGMVREVFDYFTGIAEEKQ IHYRFSTNIDELNIYIDVNKIEQVLVNIISNAFKYSDSGGDISVRITGEA ETVLLEVEDHGRGISKESMEHLFERFYTGNKTFGTVGFGIGLNLSKEYVD LHDGEIRAESQPGEYTLFSVRLYKDIAHYTHEYILEETDRFNLSYHDMEV DTTVVNEMLSKTYDYHVLVVEDDPDVRYSLRKELSANFQVEVAGNGNEAL DLLGQGDAFHLILSDVLMPGMNGFQLVNRVKNDLAFSHIPIILLTALSED SQRIYGIAEGADEYIPKPFNIDFLKIRIINIIAERQKMKEIYMKNLQAGT MDNVEVCKLMKVDELFRDKLLSIVDTQYENSDFSIEDLSEHLGLSRVHLY RKMKTLFGVSPTDYLRNYRLNKAMLLLKSRKYNISEVAYMTGFTSPAYFT KCFRTLYKVTPSEAMTT >BF0684 putative anti-sigma factor MNNLSEDILMRYLTGECSDEDFARVNAWIKESDDNARRLFRMEEVYHLGR HDSFPDQKKVARAEARLYKKLAQEDAHSRKVIRMHQWMRYAAIIVLALMI GTGGGYLYYQADPTRNMITASSTDGKVKEVMLPDGTKVWLNQSATLRYPK EFSESERDVYLDGEAYFEVTKNRRCPFVVESEAMRIKVLGTTFNFKCDKS HKLAEATLIEGEIEVRGNHDEGMIILSPGQKAELNKTTRRLVVKQVDAKL DAVWHNDLIPFEQADIFAITRTLERFYDVKIILSPDIKSDKTYSGVLKKK DNIESVLQSLDNSIPINYKIVGDNIFISSRNK >BF2368 putative regulatory protein MAEKTRYSDAELEEFRAIINEKLELAQRDYEQLKLSLMGLDGNDTDDTSP TYKVLEEGANTLSKEETTRLAQRQLKFIQGLQAALVRIENKTYGICRETG KLIPAERLRAVPHATLSIEAKNSGKK >BF2253 putative two component system sensor histidine kinase MEHSIIEAMRTSDYNEMMLRIERMRRDDQDHGEISVSAGYNDEGGTLVRS STMVHKEKIPGSRGIQQDSILKTERKLDTLIVVRNDQKEIKVVPQDSTSQ EVKAAMLQTKGGLDILLKDQNTMLELATYFQRGLHSGLDVIMDPDFQSYD SLLTLSLQERGISLPYRIEYLHFGNTPDSSLLFTDTLGMGGTANYIPGPD AHTYDYTFDIHSHSLYRLRMDSVAGVIVHQMAGILITSFVILLILGFSFW FLIRTLLKQKTLEEMKSDFTNNITHELKTPIAVAYAANDALLNFGQADEK AKRDKYLSISQEQLQRLSGLVEQILTMSMEQRKTFRLRLEEITLATLLES LTEQHKLKAQNPIDIDYRVEPANLTVFADRTHFSNILSNLIDNAVKYSPG KAVIRIHCRETADNGKVEISVSDEGTGIAQEKQKHIFDKFYRVPTGNLHN VKGYGLGLYYVKTMIEKHGGTVCVKSEPGHGSTFTITL >BF3089 putative two-component system histidine kinase/response regulator fusion protein MKNNPYTGFLTWLTVLFTVCCLPLKASHYYYKQISLKEGLPSTVRCVYTE PKGFVWIGTNAGLGRFDGQKLRKYVHRQEDVHSLPHNYIHQITEDIQHNI WILTDGGIAQYRRSSDDFAIPLDDRGHPILAYSACLTEQGVIFGGRNRIY RYDYDSRSIKLLLDFSSDPYFAISAISRWDEETLLCCSRWQGLRLINLRS GERRLPPFDCGKEIMALLIDSHNRIWLAPYNEGLRCFNPEGRLLASYTTD NSGLSNNVVLSMAERDSHIWVGTDGGGINIIHPDSHRITVLEHIPGDNYS LPVNSILSLYNDNYNNMWAGSIRKGLINIREVSMKTYTDVFPGSTQGLSD PTVLSLYQDEPNGRIWIGTDGGGVNSLDPVTEEFRHDRSTWGDKVVSITG FTRESILLSVFSRGLFVYNKENGKRKPLPIDHPDLKQYIYYSGMAVNIYR DEPGSVLLLAGHTYRYDIGSQKIRVVNEEEGMEIAGSMNAIAHNERFTYL HDSRTLYELDRTGNRLKKLFSCTGDTLLYSVSMDEKGDFWIGSNTGLGQY SIRTRQYHPLITSLFGEASSVICDHRGKVWIGADHMLFAWMLQSRKFILF GESDGVIPNEYLAKPRLVSGKGEVYMGGVNGLLCIDNRFPATSSNYPEVV LTDVRVNGEPATNRTAGNPDKLTLPQDSRAITLRVMSHEEDIFRKKRYRY RIDGLNEEPIESYDPELVIRSLPAGNYRIQAACSTQNGDWTPFHPILSLT ILPPWYRSGWFIICLLLFVSGGITAIIFAILRRRKNRLKWELKERELQEY EEKIRFLVNVSNELLPSFTEKGERELQIVELIRNRLRNGEKSKAPAEIAS SPNIVKEELSQPDETFLRKLNQLITDHLDSPELDVTFLCTEMGLSRASLY NKLKAMTNMGANDYINKFRMEKAIQLISTTDLTFTEIAEKIGFTTSRYFS TSFKQYTGETPTQYKEKIRKSSKV >BF0668 putative histidine kinase MKQEKQTELLRTQQMLNEVNRKLLMTLGVAEVFPWKWELAEHMVWFDARP SDDPAGWEIFHNDSFPVSIARVYQGIYKEDRLRVIEACRGILKGKMKKVV VELRFWAKKREGFVLEWLEMHAIPGKVDENGRLLTVEGSLMSITRRKVME EELTAAKEKAEEANRLKSALIANMNHEIRTPLNAIVGFASLLSIIDDEKE QQEYIGLIQSNTEHLLRLMNDVIDLSNIESGVMDIVGSDVVLDSLMKEME LTYVPKAETNNLVLAWDREQSNAHIYTDRDRLIQILEHLLDNAIKFTTKG TVHWGYQEKENGQIRFYVTDTGCGIPNDKKEVIFERFVKLDSFTQGLGLG LSLCKIIIERMHGTIGVESEVGEGSTFWFTIPNLSDNHI >BF2682 putative response regulator MRKLILLVDDKETIAKVASIYLGKDYDIQYFPDPIHALEWLHEGKTPDLI ISDIRMPLMRGDEFLHYLKCNELFKDIPVIMLSSEESTSERIRLLQEGAV DYILKPFNPMELKIRVKKIIE >BF2839 putative two-component system, histidine kinase MIMEKNISQEKRIEELEARLKEQEKLGSLGLLSAGIAHEIQNPLNFVINF SKLSGQLLADLADRVDEAKARIPEAELEDIKDILSGLRENVDKIKEHGDR AISIIRGILLYSRGKEDEFMPTQIQKLTKEYVWLAYHAMRANYKNFNIAI REDYAKDIPSIRLIPQDFSRAVLNVMNNACYAVWKKWQNAPEGYSPEIMV TLEKLDKRVVLSIRDNGEGMSPEVKRKLFDSFFTTKPVGQGTGLGMAIVR DIIENKHHGKVLFDSVLHEYTCFRFIIPIA >BF1872 putative two-component histidine sensor kinase MPVSFKYILYLLLLVIGCCPPMAGHAATGEKPILMICSYNPGAYPTSANV SDFMDEYQRLGGKRGVVIENMNCKSFSDFPRWKGVMENILDKYRGSQEPA LIILFGQEAWASYLSLNDSVTGEVPVMCALTSRNVVLLPDDGKDLAHWMP ESSDFYEDSLKHQVCGGFLYEYDIASNIRMIRAIYPDTKNIAFISDNTYG GVTLQAHVRKEMKQFPDMNLILLDGREHTIYTIVDELRKLPKHTAVLLGT WRVDKNEGYFMRNATYSMMEAIPDVPTFTATSIGLGYWAVGGVVPVFRTF GKGLAEEAVKLLDNPEDPNMRVEVVGTEALLDSKKVKEQKIDVAALPMKV KLVNESPSFYKQYRYQIWVGVGVLCILVIGLLVSIYFYLRTKRLKDDLER SQVALYEAKDRAEESNRLKSAFLANMSHEIRTPLNAIVGFSDVLASGGSS EEDQRNYFRIIQSNSDLLLRLINDILDLSRLEANKVILTPEDCDVVQLCR QALSSVEMSRRESGNRFVFETKTDSFVLQTDIQRLQQVLINLLTNAAKFT KNGTITLQFEVEKEKNRVLFAVADTGCGIPKEKQKQVFERFEKLNEYAQG TGLGLSICKLTVDKWGGDIWIDPDYEGGARFVVSHPL >BF0533 frrD, putative two-component sensor histidine kinase MNIKTKLLFGIGILAGMIILLVTLSVVNLQILTATEPDSPVAMPALERAL LWISVTGGICILTGLVLLIWLPRSINRPVKELTCGILEIANHNYEKRLDM RGYEEFREVSDSFNRMAEKLTEYRDSTLADILSAKKFLEAVVNSIHEPII GLNTEREILFINNEALNVLNMKRENVIRKSAEELSLKNDLLRRLIRELVT PGEKNEPLKIYADNKESYFQASYIPIENAAAEEGEARNLGDVILLKNITE FKELDSAKTTFISTISHELKTPISAIMMSLQLLEDKRVGSLNGEQEQLSK NIRDNSQRLLDITGELLNMTQVEAGKLQMMPKITKPIELIEYAIKANQVQ ADKFNIQIEVDYPQEKIPKLFVDSEKIAWVLTNLLSNAIRYSKENGRVVI GVRHKKEYIELYVQDFGKGIDPRYHQSIFDRYFRVPGTKVQGSGLGLSIS KDFVEAHGGTLTVQSEPGKGSCFVIRLKA >BF0535 frrF, putative anti-sigma factor MSYLKNIITYFFHHPASDGVVERVHQRLADTNSGQEKEEVLSGIWEQIGF PQADEHQTLRAFEKLEQQIGGDSLKSESSFSRFRIPRWSWIAASIIVPLL LLFGSAYLYKETLTIKNELSNVTFIQYYVSNGKREQVTLPDRSKVWLNSG SLLIYPSAFIGNEREVYLAGEGYFSVTKDKECPFIVKTNSVSVSVLGTEF NINAYPNIDKVVTTLEEGSIRMSLNRFDSSYLLEPDDQIVYIPSTGHIER KRVKASDYSDWRGGGLYFSNSPFKEVIQTIERTYSVQVHLQTSIYQSNNL TIHFYPNESIENIMMLIKEMIPGLEYQIEGKDIYID >BF0532 kdpD, putative osmosensitive potassium transport sensor protein MDREESVQHFLDLIKKSRRGKFKVYIGMIAGVGKSYRMLQEAHDLIDNGV DVRIGYIETHGRAGTEALLKGLPVIRRRKLFYKGKELEEMDLEAIIRIHP EIVIVDELAHTNVEGSLNEKRWQDVMTLLDEGINVISAVNIQHIESVNEE VQDIAGIEVKERIPDSVLQEADEVVNIDLTAEELITRLKAGKIYKPEKIQ TALNNFFKTENILQLRELALKEVALRVEKKVENEVVMGIGLGVRHEKFMA CISSQEKTPRRIIRKVARLATRYNTSFVALYVQVPKESMERIDLASQRHL LNHFKLVTELGGEVVQVQSKDILGSIVQVCKEKQISTVCMGSPGLRLPGA LCSVLKYRRFLNNLAQANIDLIILA >BF2223 relA, GTP pyrophosphokinase MERDEFFTKEERELLFSLYKKLLRLTGETLQKGDCRKLKKHLIDSTQNNT MQRDSFGLNPVIKDMQTAVIVAEEIGMKRASILGIMLHTPVRCHSYTIEY IQQEYGEDVAGIIRGLIKINDLYDKSPTIESENFRNLLLSFAEDMRVILI MIADRVNVMRQIKDAENDEARRRVANEAAYLYAPLAHKLGLYKLKSELED LSLKYTEHDIYYHIKEKLNETKKSRDRYIANFIAPIQQKLEEAGLHFHMK GRTKSIHSIYQKMKKQKCQFENVYDLFAIRIILESQFEKEKQECWQAYSI VTDMYQPNPKRLRDWLSVPKSNGYESLHITVMGPEGKWVEVQIRTERMDD IAERGLAAHWRYKGVKGESGLDEWLTSIREALENTENDLEMMDQFKLDLY EDEVFVFTPKGDLFKLGKGATVLDFAFHIHSKLGCKCIGAKVNGKNVQLR QKLNSGDQVEIMTSNTQTPKQDWLNIVTTSKARTKIRQALKEMVARQHDF AKETLERKFKNRKMEYDEAVMMRLIKRLGFKNVTEFYQKIADEVLDVNDI LDKYIEQQKRDSERDEVTYRSAEEYNLQNQIDETTVTKEDVLVIDQNLKG LDFKLAKCCNPIYGDDVFGFVTVSGGIKIHRNDCPNAGQMRERFGYRIVK ARWAGKSEGTQYPITLRVVGHDDIGIVTNITSIISKENGISLRSIGIDSN DGLFSGTLTIMVSDTGRLEALIKKLRTVKGVKQVSRN >BF3635 rprX, two-component regulatory system, sensor kinase protein MKKSTIWILGIIMGLSFLSLLYLQVSYIEEMVKMRKEQFNTSVRNALFQV SKDVEYDETQRWLLEDITEAERRALAQSSSTTEQKNGLIQQSERYRFKSP DGTLYSEFELKMITTEPSKVPKAMISERHGRNTIPQTSRSLTDAIKNRYM YQRFLLDDVALRMIYKASDKSIGERVNFKKLDNYLKSNFINNGVELLYHF SVIDKDGREVYRCSDYEDGGSEDSYTQPLFQNDPPAKMSIVKVHFPGKKD YIFDSVSFMIPSMIFTIVLLITFIFTIYIVFRQKKLTEMKNDFINNMTHE FKTPISTISLAAQMLKDPAVGKSPQMFQHISGVINDETKRLRFQVEKVLQ MSMFDRQKATLKMKELDANELITGVINTFALKVERYNGKITSNLEATNPV IFADEMHITNVIFNLMDNAVKYKKPEEDLVLNVRTWNEPGKLMISIQDNG IGIKKENLKKVFDKFYRVHTGNLHDVKGFGLGLAYVKKIIQDHKGTIRAE SELNVGTKFIIALPLLKND >BF3634 rprY, two-component system, transcriptional regulatory protein MIDMDEKLRILLCEDDENLGMLLREYLQAKGYSAELYPDGEAGFKAFLKN KYDLCVFDVMMPKKDGFTLAQEVRAANAEIPIIFLTAKTLKEDILEGFKI GADDYITKPFSMEELTFRIEAILRRVRGKKNKESNVYKIGKFTFDTQKQI LAIGDKQTKLTTKESELLGLLCAHANEILQRDFALKTIWIDDNYFNARSM DVYITKLRKHLKDDDSIEIINIHGKGYKLITPEPES >BF1529 rteA, putative two component system sensor kinase MKSIKNLISLGYLLMALLVIGIMYIWYKEWCDLEKLEVQNRHIDTFRQES HEIFVFLIELSLSGETVLEWEDADLEHYHYQRMAIDSMLCRFKTIYPTER IDSVRHLLEDKERQMRQIVQVFEQQQAINDKITRQVPIIVQKSVQEQPQK PKRKGFLGIFGKKEKPKPTVTTTMLRSLDRDMITEQQTQSRRLSEHTDSL AVRNAELNRQLHGFIHQMDKKVQADLQKREAEITAMGEQSFMQIGSLTGF VLLLLVISYIIIHRNANRIKRYKQKTTDLIGQLQQSVEQNEALIASRKKA VHTITHELRTPLTAIIGYTSLMEKGNEAVMLDKLITETEKEMQAIREAGL KKDLQELDALTHHLRSSWEILRADQPLRELYKLLHCDGTPDDKTIGNAVK AVLDKGSEIIRLAKEERRKYENG >BF1530 rteB, putative two-component system response regulator MDKTKIIVVEDNIVYCEFVCNLLVREGFRTVQAFHLSTAKKYLQQAADGD IVVSDLRLPDGNGIDLLRWMRKEGMMQPFIIMTDYAEVHTAVESMKLGSL DYIPKQLVEDKLVPLLRTILKERNIGRNRMPVFSRDGSAFKDIMKRIRLV APTDMSVLIFGENGTGKEHIAHLLHDKSKRAGKPFVAVDCGSLTKELAPS AFFGHVRGAFTGADSTKKGYFHEAEGGTLFLDEVGNLAPETQQMLLRAIQ ERRFRPVGDKSDRSFNVRIIAATNEDLEKAVHEKRFRQDLLYRLHDFEIT VPPLRDCQEDVMPLAEFFREIANRELECDVIGFDGEARKTLLTHAWPGNV RELRQKIMGAVLQAQTGLVTKEHLELAVTRATSPVSFALRSDAEDKERVL RALKQANGNRKVAAELLGIGRTTLYNKLEEYGLKYKFQQP >BF4258 typA, putative GTP-binding elongation factor family protein TypA/BipA MQNIRNIAIIAHVDHGKTTLVDKMLLAGNLFRGNQTSGELILDNNDLERE RGITILSKNVSINYNGTKINIIDTPGHSDFGGEVERVLNMADGCILLVDA FEGPMPQTRFVLQKALEIGLKPIVVINKVDKPNCRPDEVHEMVFDLMFSL DATEEQLDFPTIYGSAKNNWMSTDWKEQTDSIVPLLDCIVENIPAPEQLE GTPQMLITSLDYSSYTGRIAVGRVHRGTLKEGMNVSLAKRDGSIVKSKIK EVHVFEGLGRVKTTEVSSGDICALVGIDGFEIGDTICDYETPEALPPIAI DEPTMSMLFAINDSPFYGKDGKFVTSRHIHDRLTKELDKNLALRVRKSEE DGKWVVSGRGVLHLSVLIETMRREGYELQVGQPQVIYKEIDGVKCEPIEE LTINVPEEYSSKIIDMVTRRKGEMTMMENTGERINLEFDMPSRGIIGLRT NVLTASAGEAIMAHRFKEYQPFKGDIERRTNGSIIAMESGTAFAYAIDKL QDRGKFFIFPQEEVYAGQVVGEHAHEKDLVVNVTKSKKLTNMRASGSDEK ARLIPPVQFSLEEALEYIKEDEYVEVTPKAMRMRKVILDETERKRANKS